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Abstract

COMPUTATIONAL MODELING OF RNASMALL MOLECULE AND RNA-PROTEIN
INTERACTIONS
By Lu Chen, B.S.
Advisor: Shuxing Zhang, Ph.D.

The past decade has witnessed an era of RNA biology; despite the considerable discoveries
nowadays, challenges still remain when one aims to screen RNA-interacting small molecule
or RNA-interacting protein. These challenges imply an immediate need for cost-efficient
while predictive computational tools capable of generating insightful hypotheses to discover
novel RNA-interacting small molecule or RNA-interacting protein. Thus, we implemented
novel computational models in this dissertation to predict RNA-ligand interactions (Chapter
1) and RNA-protein interactions (Chapter 2).

Targeting RNA has not garnered comparable interest as protein, and is restricted by lack of
computational tools for structure-based drug design. To test the potential of translating
molecular docking tools designed for protein to RNA-ligand docking and virtual screening,
we benchmarked 5 docking software and 11 scoring functions to assess their performances in
pose reproduction, pose ranking, score-RMSD correlation and virtual screening. From this
benchmark, we proposed a three-step docking pipelines optimized for virtual screening
against RNAs with different flexibility properties. Using this pipeline, we have successfully
v

identified a selective compound binding to GA:UU motif. Both NMR and the subsequent MD
simulation proved its selective binding to GA:UU motif flanked by two tandem flexible base
pairs next to GA. Consistent to the 3D model, SAR analysis revealed that any R-group
substitution would abolish the binding.

Current computational methods for RNA-protein interaction prediction (sequence-based or
structure-based) are either short of interpretability or robustness. Aware of these pitfalls, we
implemented RNA-Protein interaction prediction through Interface Threading (RPIT), which
identifies and references a known RNA-protein interface as the template to infer the region
where the interaction occurs and predict the interacting propensity based on the interface
profiles. To estimate the propensity more accurately, we implemented five statistical scoring
functions based our unique collection of non-redundant protein-RNA interaction database.
Our benchmark using leave-protein-out cross validation and two external validation sets
resulted in overall 70%-80% accuracy of RPIT. Compared with other methods, RPIT offers an
inexpensive but robust method for in silico prediction of RNA-protein interaction networks,
and for prioritizing putative RNA-protein pairs using virtual screening.
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Chapter 1: Introduction
1.1 Targeting RNA with small molecules
1.1.1 RNA as therapeutic target
Recent advancements in RNA biology refresh our understandings of life and potentiate the
strategy of targeting RNA for a large multitude of diseases. DNAs and proteins have received
much attention as therapeutic targets of small molecules, but RNAs have not garnered
comparable interest for a variety of reasons including relatively few and ill-defined structures,
the intrinsic dynamics of RNAs, and sometimes less appreciated link between RNA
molecules and biological functions. Historically, targeting RNA for therapeutic development
has been envisaged by many to be a cost-expensive strategy. However, several pioneer studies
have provided proof-of-principles that targeting RNA is a feasible strategy for treatment
infectious diseases and cancers. Targets that are mostly investigated includes prokaryotic
rRNA A-site [1-3], HIV-1 TAR RNA [4-6] and riboswitches [7-9]. Furthermore, researchers
are exploring new-generation, drug-like compounds for disease-related RNAs including
CUG- or CCUG-repeated mRNA [10-12], miRNA [13, 14] and internal ribosome entry site
(IRES) [15, 16]. All these efforts represent a paradigm-shift strategy to target a more
upstream biomolecule, that is, hub RNA, which regulates multiple disease-related proteins.

1.1.2 Hit identification via molecular docking
A number of strategies have been used for lead identification targeting RNA, including highthroughput screening, rational design by NMR or computational modeling. Conventional
high-throughput small molecule screening methods are well-suited to catalysis-based assays,
1

but are limited in screening compounds for RNA binding by detection assays that generally
rely on binding-coupled conformational changes which compete with intrinsic RNA
dynamics. Therefore, virtual high-throughput screening (vHTS) using molecular docking has
become one of the core lead discovery technologies in the pharmaceutical industry [17],
which provides a practical route to identify more selective RNA-binding compounds in a
more efficient fashion.

Molecular docking is one of the key strategies for computational structure-based drug design
[18]. The goal of molecular docking is to predict the favored binding mode of a small
molecule (ligand) in a macromolecule pocket (e.g., protein or nucleic acid) with respect to the
3D structure [19]. Docking has become a popular structure-based approach to prioritize active
compounds from a large chemical database prior to expensive and time-consuming
experimental validation. In general, molecular docking procedure can be divided into two
steps: conformational sampling and scoring. During the conformational sampling phase, a
large amount of ligand conformations and coordinates will be numerated and submit a few to
the second phase based upon a fast, but less accurate scoring function which roughly
evaluates the fitness of binding. In the second phase, a more accurate but more complicated
scoring function will be applied to differentiate the “good” (energetically-favored) poses
against the “bad” (energetically-prohibited) poses. Although ranking compounds according to
relative binding affinity still remain challenging, docking-based virtual screening has been
employed for lead identification and optimization for a number of protein targets, which has
been reviewed by Chen et al. [18].
2

1.1.3 Current in silico methods of targeting RNA
Like protein, RNA can fold into well-defined tertiary structures (such as helix, hairpin, bulge
and pseudoknot), providing the structural basis for structure-based rational design. There have
been several studies which aim to translate the docking/scoring functions that have led to
great successes for protein targets, but are parameterized exclusively using protein-ligand
complex, to RNA target. For example, GOLD and Glide [20] and AutoDock4 [21, 22] have
been benchmarked for their usage in docking small molecules to RNA receptor. Others were
seeking to implement RNA-specific scoring functions, e.g., force field-based scoring
functions based implicit solvent models [23], empirical scoring function [2, 24, 25] and
knowledge-based scoring function [26]. The tools that model a flexible RNA receptor, such as
MORDOR (molecular recognition with a driven dynamics optimizer) [27], may give more
accurate predictions, yet not feasible to screen a large chemical database. None of these
computational tools have been benchmarked using publicly available dataset, and thus the
predictive capability of these models still remains ambiguous. Actually, we have found that
the docking parameters widely used in proteins may not be well translated to RNA systems.
For instance, electrostatic attraction between RNA backbone and positively charge group
(such as piperazine) can be overestimated [23, 28, 29], and desolvation term need
improvement [21]. Hence, we believe that a mature structure-based modeling technique
designed specifically for RNAs, e.g., docking-based virtual screening, is still lacking, despite
the efforts mentioned above.
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1.2 Discovering novel RNA-protein interaction
1.2.1 Emerging RNA-protein interactions (RPI)
The past decade has witnessed an era of RNA biology: new RNA, new functionalities, and
new interactions. RNA-protein interaction (RPI) takes a major proportion in these exciting
discoveries, owing to its critical roles in cellular processes, such as transcription, translation
and regulation [30]. Ribosome and spliceosome are the two well-known examples of large
bio-machineries involving complex RPI. Various non-coding RNAs, such as microRNA
(miRNA), long non-coding RNA (lncRNA) and Piwi-interacting RNA (piRNA), interplay
with a large number of proteins via indirect mechanism or direct binding [31]. For example, a
vast majority of lncRNA reported in the literature is able to form machinery with multiple
proteins. lncRNA that folds into complex tertiary structure has been shown to modulates the
transcriptional factors that regulate the gene-specific transcription, basal transcription
machinery, splicing and translation [32]. Recent discoveries of new functionalities of miRNA,
e.g., direct binding to hnRNP-E2 [33], ELAVL1 [34], or being the native ligand of Toll-like
receptors (TLR) [35, 36], have updated the dogmatic understanding of microRNA. On the
other hand, more studies focused on the biogenesis of miRNAs, which is regulated at
posttranscriptional level via various RNA-binding proteins (e.g., hnRNPA1 [37-39], PTBP1
[39], KSRP [40-42], Lin28 [43]). piRNA is another representative protein-binding non-coding
RNA that form RNA-protein complexes through interacting with piwi proteins [44]. This RPI
mediates the epigenetic and posttranscriptional gene regulations, especially in germline cells
[45].

4

1.2.2 RNA-protein interface
Current understandings of RNA-protein binding interface primarily come from the analysis of
high resolution structures. For example, several analyses based upon small datasets from PDB
(81 complexes [46], 54 crystal structures [47], 77 complexes [48], 41 complexes [49], 89
complexes [50], 152 complexes [51]) have provided insightful knowledge of the
physicochemical patterns that are essential to form a RPI. Despite the trivial differences
between studies, most of them did reach a consensus. From a structural perspective, Huang et
al. summarized four features of RPI interfaces that are significantly different from PPI
interface: (1) The atomic packing of RPI interfaces is looser than that of PPI interfaces; (2)
There is a strong residue preference at RPI interface-positively charged residues are
significantly favored (Arg and Lys) whereas negatively charged residues (Asp and Glu) are
disfavored; (3) Stacking interaction plays a more critical role in RPI than PPI, especially the
π-π stacking between aromatic amino acids (His, Tyr and Trp) and nucleotide base; (4)
Secondary structure states of amino acids and nucleotides are important at RPI interface [52].
All these RPI-specific features should be considered when one designs statistical scoring
functions to assess the fitness of RNA-protein binding. These signatures, however, bring both
insights and challenges. With respect to feature (1), macromolecular docking, which
determine the fitness of binding based on structural complementarity between RNA and
protein, is historically optimized to result a compact interface. As to feature (2), despite the
preference of positively-charged protein residue at the interface, the contributions of such
electrostatic attraction to RNA-protein binding affinity can be easily overestimated, compared
with other more sequence-specific type of interaction. Regarding feature (3), to the best of our
5

knowledge, there is no grounded mathematical model to quantitatively evaluate the
propensity of stacking. Finally, unlike secondary structure states of protein residues, which
have 3 major clusters (helix, sheet and coil), the base pairing states of nucleic acid is more
complicated. Other than well-defined Watson-Crick and G-U wobble base pairing, there are
still hundreds of noncanonical base pair types, triplex or quadruplex [53]. Other than the
challenges from the modeling perspective, the statistical significance of these conclusions still
remain elusive due to the paucity of 3D structure of protein-RNA complexes. Thus, it is
crucial to perform more comprehensive structural analyses using a larger dataset to achieve
greater statistical power and make more accurate inferences on the protein-RNA binding
patterns when designing scoring functions in RPI prediction.

1.2.3 Current in silico methods of predicting RPI
In sharp contrast of advancements in RNA biology, there are only 1,585 protein-RNA
complex structures deposited in PDB as of April 2014, which only represents a tiny island
(<1.5%) compared with all macromolecular structure repository in PDB. Due to the technical
issue in solving crystal/NMR structure of protein-RNA complex, high-throughput
experiments to identify RPI are being developed to provide better understanding of the
complex RPI networks, but they are usually expensive and time-consuming. As a
consequence, there are immediate needs of developing computational tools for RPI prediction
that help generate valuable hypotheses and prioritize insightful RPIs for experimental
validation.

6

From the best of our knowledge, current computational methods of predicting RPI fall into
two categories: sequence-based and structure-based methods. RPISeq [54] and catRAPID [55]
are sequence-based methods. RPISeq utilizes machine learning classifiers to predict proteinRNA interaction propensity purely from sequence information, whereas catRAPID calculates
the protein-RNA interaction propensity through combining various physiochemical
properties, such as H-bond, vdW, secondary structure. Structure-based methods take
advantage of 3D structures of protein and RNA, and employ molecular docking strategy to
evaluate the structural complementarity based on RNA-protein statistical scoring function.
For example, Péres-Cano et al. developed a new protein-RNA docking scheme in which
FTDock was used to generate rigid-body binding modes and rescored by an in-house derived
statistical amino acid-nucleotide potential [56]. Similarly, 3dRPC applied a novel protocol
including two modules, RPDock and DECK-RP [52]. RPDock is a new docking procedure
that discretizes molecules and charges, and considers geometric and electrostatic
complementarities as well as stacking interactions. DECK-RP is a coarse-grained,
knowledge-based statistical potential to evaluate the predicted RNA-protein complex, which
takes into account the secondary structure and interface preferences of protein/RNA residues
[52]. Other efforts on the development of protein-RNA statistical potentials, such as DARSRNP, QUASI-RNP[57] and Li et al.[58], have resulted in comparable performances
according to their benchmarks. However, either sequence-based or structure-based methods
have its merits and pitfalls. Sequence-based method is based on simple assumption and
thereby more robust, for example, using conjoint triad descriptors [59]; however, it could be
sensitive to noise as it fails to discriminate the interface with other part of the molecule.
7

Structure-based method, on the other hand, restricts its application only for the protein / RNA
targets that have 3D structure. Therefore, a method that balances the robustness and accuracy
of RPI prediction is urgently needed.

8

Chapter 2: Computational modeling of RNA-small molecule
interaction

Chapter 2.1-2.5 is based upon and reprinted with permission from Chen L, Calin GA, Zhang
S. Novel insights of structure-based modeling for RNA-targeted drug discovery. J Chem Inf
Model. Oct 22 2012;52(10):2741-2753. Copyright© 2012 American Chemical Society.

2.1 Introduction
Due to the challenges we have described in Chapter 1.1, we think there is an immediate need
of exploring current computational tools and implementing new ones to model RNA-ligand
interaction more accurately, and prioritize compounds via virtual screening more effectively.
Herein, we have benchmarked 5 popular docking programs, including GOLD 5.0.1 [60],
Glide 5.6 [61], Surflex 2.415 [62], AutoDock 4.1 [63, 64] and rDock 2006.2 [24], and 11
scoring functions to explore their capability in RNA-small molecule docking. Fig. 2.1 shows
an overview of structure-based virtual screening pipeline. A typical structure-based virtual
high-throughput screening (vHTS) can be divided in to three steps: sample ligand
conformations (step 1), score and rank the poses for each molecule based on a scoring
function (step 2), score and rank the molecules and estimate the relative binding affinity for
the optimal pose provided by step 2 based on a second scoring function (step 3). The
rescoring scheme is believed to improve the results when two scoring functions have
complementary strengths: one is better at ranking poses and the other ranking actives [65].
Based on this “complementary” hypothesis, we comprehensively evaluated the docking
9

performances at these three levels, and explored exhaustively for the best docking-scoringrescoring strategies using various statistical metrics. As a result, we proposed a rational
workflow for structure-based modeling for RNA-targeted drug discovery for RNA, which has
demonstrated a significant improvement of virtual screening enrichment in two independent
benchmarks [66].

In a follow-up case study, we validated the effectiveness of our pipeline in which we have
successfully identified small-molecule inhibitor that binds selectively to RNAs containing
GA:UU internal loop motif. NMR validated the binding site specificity and the essential

context adjacent to the motif. This tandem mismatch internal loop,

5' GUGA3'
(or called
3' CUAU 5'

GA:UU RNA), is a highly conserved motif in prokaryotic large ribosomal subunit (LSU) as a
part of a conserved 58-nt fragment. It is the binding domain of ribosomal protein L11, and
this thermodynamically destabilizing internal loop is crucial for binding of L11 [67]. The
discovery of small-molecule binder targeting this rRNA motif has the potential to destabilize
the L11 binding. From the druggability perspective, selective small molecule inhibitor
targeting prokaryotic rRNA internal loop, such as A-site, has been proved an effective
strategy of designing antibiotic drugs. However, the most thoroughly studied RNA-binding
antibiotics, notably aminoglycosides, have very low bioavailability. Development of nonaminoglycoside antibiotics targeting bacteria rRNA will improve the pharmacokinetics
profiles and provide possible solution to overcome drug resistance.

10

Here we hypothesize that RNA-small molecule docking composed of three independent steps,
each of which needs a fine-tuned docking/scoring combination to maximize the predictive
ability in a virtual screening scenario. In order to validate our hypothesis, we proposed
several specific aims:
1. Benchmark open-source and commercially available docking/scoring method to
identify best strategy for pose reproduction, pose ranking and active ranking.
2. Knowing the challenge in active ranking, optimize the scoring function so that the
docking score has a better representation of the experimentally determined binding
affinity for RNA-small molecule interaction.
3. Apply the derived structure-based drug discovery pipeline to a real-world problem: to
identify novel inhibitors that bind selectively to GA:UU RNA motif.

2.2 Materials and Methods: Benchmarking, Development and Application
2.2.1 Benchmark datasets
Most of the currently published datasets are either too small or lack target diversity [20, 21,
23, 24, 26, 27]. Based on these datasets, we compiled our own dataset of high-resolution
RNA-ligand complex structures by removing those low-resolution, redundant structures as
well as those structures with critical structural defects. This resulted in a unique collection of
56 RNA-ligand complex structures with 36 high-resolution (<3.0Å) crystal and 20 NMR
structures. Another issue of the published datasets was that over 65% of the ligands were
aminoglycosides or low-affinity binders (e.g. spermine) [20]. To avoid the potential problems
of overweighting any type of RNA ligand, we reduced the number of aminoglycosides and
11

low-affinity binders, but increased the number of high-affinity small molecules. Our curation
encompassed a large variety of RNA targets including: RNA aptamers, prokaryotic and
eukaryotic rRNA A-sites, ribozymes, riboswitches, and viral RNAs (TAR RNA, HCV IRES
domain, etc.). These RNA-small molecule complexes are listed in Table 2.1.

We also compiled a second dataset which contains 45 RNA-ligand binding affinity values for
benchmark currently available scoring functions and to derive RNA-specific docking scoring
function (Table 2.2). Briefly, dissociation constant (Kd) or binding free energy values were
carefully collected from literature, and we compared them with PDBBind database
(http://www.pdbbind-cn.org) [69] and other reports/databases to ensure the consistency. If the
variance between Kd values is within 10-fold difference, we calculated the average values;
otherwise, data will be discarded. Notably, we used 2 µM as the Kd of gentamicin C1a-rRNA
A-site complex (1BYJ) because this is the Kd under room temperature, instead of 0.01µM (Kd
under 4°C) [70]. In addition, Kd for neomycinB-HIV-1 TAR RNA complex (1QD3) should be
5.9±4µM. The Kd values used in previous studies were for U24C TAR RNA mutant [21, 24,
71]. The binding free energy were converted from Kd using ΔG = RTln(Kd) under room
temperature (300K).

12

Fig. 2.1. An overview of structure-based virtual screening pipeline. A typical virtual
screening can be divided into three steps: for each candidate molecule, docking program should
do conformational sampling (step 1) and select an optimal pose based on a scoring function
(step 2). An additional scoring of the optimal pose for each molecule might be performed after
pose selection to estimate the relative binding affinity (step 3). Finally, the molecules that have
good predicted binding affinity will be prioritized for experimental validation.
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Table 2.1 List of 56 PDBs used in binding mode reproduction study
PDB ID

Res (Å)

Ligand

RNA

1F1T

2.8

N,N'-tetramethyl-rosamine

Malachite green aptamer RNA

1F27

1.3

Biotin

Biotin-binding aptamer RNA

1J7T

2.5

Paromomycin

Bacterial rRNA A-site

1NTB

2.9

Streptomycin

Streptomycin RNA aptamer

1YRJ

2.7

Apramycin

Bacterial rRNA A-site

2F4T

3

Designed antibiotics

Bacterial rRNA A-site

2FCZ

2.01

Ribostamycin

HIV-1 DIS Kissing loop

2ET8

2.5

Neamine

Bacterial rRNA A-site

2O3V

2.8

Paromamine derivative NB33

Human rRNA A-site

2OE8

1.8

Apramycin

Human rRNA A-site

1LC4

2.54

Tobramycin

Bacterial rRNA A-site

1MWL

2.4

Geneticin

Bacterial rRNA A-site

1U8D

1.95

Hypoxanthine

xpt-pbuX B. subtilis guanine riboswitch

1Y26

2.1

Adenine

Vibrio vulnificus adenosine riboswitch

2BE0

2.63

Paromomycin Derivative JS5-39

Bacterial rRNA A-site

1YKV

3.3

DAI

Diels-Alder ribozyme

2G5Q

2.7

Amikacin containing L-haba

Bacterial rRNA A-site

2GDI

2.05

Thiamine Diphosphate

2GIS

2.9

S-Adenosylmethionine

3LA5

1.7

Azacytosine

Thiamine pyrophosphate-sensing
riboswitch.
S-adenosylmethionine riboswitch (T.
tengcongensis)
Engineered A-riboswitch

3F2Q

2.95

Flavin mononucleotide

Flavin mononucleotide riboswitch

3DIL

1.9

Lysine

Thermotoga maritima Lysine riboswitch

2Z74

2.2

Alpha-D-glucose-6-phosphate

T. tengcongensis glmS ribozyme

2Z75

1.7

glucosamine 6-phosphate

T. tengcongensis glmS ribozyme

1ZZ5

3

Neomycin Derivative

rRNA A-site

3Q3Z

2.51

C-di-GMP

2ESI

3

Kanamycin A

Clostridium acetobutylicum c-di-GMPbinding riboswitches
Bacterial rRNA A-site

2FD0

1.8

Lividomycin

HIV-1 DIS Kissing loop

3NPQ

2.18

S-adenosylhomocysteine

2PWT

1.8

3DVV

2

L-HABA containing
aminoglycoside
Ribostamycin

Ralstonia solanacearum S-adenosyl-(L)homocysteine (SAH) riboswitches
Bacterial rRNA A-site

3GX2

2.9

Sinefungin

1Y27

2.4

Guanine

3GX3

2.7

SAH

3GX5

2.4

SAM

3GX7

2.95

SAM

1FMN

NMR

Flavin mononucleotide

T. tengcongensis SAM-I riboswitch
(variant)
T. tengcongensis SAM-I riboswitch
(variant)
T. tengcongensis SAM-I riboswitch (double
mutated variant)
FMN aptamer

1UUD

NMR

P14

HIV-1 TAR RNA

HIV-1 F DIS extended duplex
T. tengcongensis SAM-I riboswitch
(variant)
Bacillus subtilis G-riboswitch xpt
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2KU0

NMR

ISI

HCV IRES domain IIa RNA

1AM0

NMR

AMP

AMP aptamer

1LVJ

NMR

PMZ

HIV-1 TAR RNA

1TOB

NMR

Tobramycin

antibiotic-RNA aptamer

1EHT

NMR

Theophylline

Theophylline-binding RNA

1BYJ

NMR

Gentamicin C1

Bacterial rRNA A-site

1PBR

NMR

Paromomycin

Bacterial rRNA A-site

1AKX

NMR

Arginine

HIV-2 TAR RNA

1FYP

NMR

Paromomycin

Human rRNA A-site

2KGP

NMR

Novantrone

tau pre-mRNA splicing regulatory element

1EI2

NMR

Neomycin

1KOD

NMR

Citrulline (arginine derivative)

RNA major groove in Tau Exon 10 splicing
regulatory element
Citrulline aptamer

1QD3

NMR

Neomycin B in the minor groove

HIV-1 TAR RNA

1KOC

NMR

Arginine

arginine aptamer

1NEM

NMR

Neomycin B in the major groove

Neomycin B RNA aptamer

2TOB

NMR

Tobramycin

tobramycin-RNA aptamer

2KTZ

NMR

ISH

HCV IRES domain IIa RNA

1Q8N

NMR

Malachite green

Malachite green aptamer RNA
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Table 2.2 Experimental binding free energy values used for benchmarking and
optimizing score functions
PDB ID

Type

1F1T 1

Crystal

Binding free
energy (kJ/mol)
-42.23

1F27

1

Crystal

-29.8

KD ≈ 6.0µM

1J7T

2

Crystal

-38.47

Kd = 0.2±0.042µM

Dissociation constant
KD ≈ 0.04µM

Crystal

-34.46

Kd ≈ 1µM

1YRJ

1,2

Crystal

-30.91

Kd = 2±0.20µM/6.3µM

2F4T

1,2

Crystal

-32.49

Kd = 2.2±0.1µM

2FCZ

1,2

Crystal

-28.62

Kd = 10.4±1.4µM

2ET8

1,2

Crystal

-27.99

Kd = 7.8µM/19±1µM

Crystal

-30.21

Ka = 1.8±0.1×105 µM-1

1,2

1NTB

1,2

2O3V

2OE8 1

Crystal

-36.19

Kd = 0.5µM

1LC4

1,2

Crystal

-33.06

Kd = 1.5µM/2±0.22µM

1U8D

1

Crystal

-35.24

Kd = 0.732µM

Crystal

-28.72

Kd ≈ 10µM

Crystal

-34.46

3DIL

Crystal

-40.2

3Q3Z 1

Crystal

-49.72

Kd = 1±0.016µM
Kd = 0.10±0.03µM (with K+ and
Mg2+)
Kd = 0.0022±0.0002µM

2ESI

Crystal

-27.25

Kd = 18µM

2FD0 2

Crystal

-43.04

Kd = 0.032±0.007µM

3GX3

Crystal

-23.83

Kd = 71±2µM

3GX5

Crystal

-39.55

Kd = 0.13±0.01µM

3GX7

Crystal

-25.89

Kd = 31±1µM

NMR

-35.9

NMR

-32.08

NMR

-28.5

1

1YKV
3LA5

1

1FMN 1
2KU0

1,2

1AM0
1LVJ

NMR

-39.97

1TOB

2

NMR

-52.2

1EHT

1

NMR

-36.5

1BYJ 1,2

NMR

-32.73

1PBR 1,2

NMR

-38.2

1EI2 1,2

NMR

-34.23

NMR

-23.8

NMR

-30.03

NMR

-24.1

NMR

-39.9

1KOD

1,2

1QD3
1KOC 1,2
1NEM

1

KD = 2.6µM

Kd = 2.0µM (room temperature) /
0.01µM (4°C)

KD = 5.9±4µM; KD = 0.92µM
(U24C mutant)
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2TOB 2

NMR

-51.2

2KTZ 1,2

NMR

-28.98

Kd = 9µM

NMR

-35.02

KD = 0.8µM

3SD1 3

Crystal

-27.25

2YGH 3

Crystal

-37.38

3SKI 3

Crystal

-40.20

KD,app = 18±1µM
Kd = 0.31±0.06µM (G2na
mutation)
KD = 0.1±0.01µM (20mM Mg2+)

1

1Q8N

2L94

3

NMR

-19.78

Kd,app = 360±26µM

3GER

3

Crystal

-34.75

KD = 0.89±0.06µM

2G5K

3

Crystal

-36.19

Kd = 0.5µM

2BEE

3

Crystal

-40.20

Kd = 0.1µM

2BE0 3

Crystal

-39.55

Kd = 0.13µM
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2.2.2 Molecular docking and decoy generation
Throughout Chapter 1, we denoted “A:B” as the method that “docking using A program and
scoring with B scoring function”. RNA molecules and ligands were prepared using Protein
Preparation Wizard (Maestro). For NMR structures, we used the average structure and energy
minimized. All of RNA phosphates were manually deprotonated in case of software errors.
The ligands were protonated/deprotonated using Epik (Schrödinger) at PH 7.0 [72]. If RNA
has symmetric binding sites and identical ligands, the region with the lowest B-factors was
retained. The ligands were minimized, and molecular docking and rescoring were performed
using the similar approaches as previously described [66]. Briefly, we benchmarked five
docking programs (GOLD 5.0.1, Glide 5.6, Surflex v2.415, AutoDock 4.1 and rDock 2006.2)
combined with their native scoring functions to generate 10 poses using the parameters in
Appendix 1. In order to ensure the high diversity and quality of the conformational decoys,
we employed GOLD:GOLD Fitness to generate 100 conformational decoys for each RNAcompound complex using the tuned parameters for genetic algorithm.

2.2.3 Evaluation of pose reproduction
Both RMSD between experimental structures and predicted docking poses and pose ranking
were considered. To simplify the expression, we defined C(x, y) as the criterion that “at least
one pose (RMSD < yÅ) was predicted within the top x poses”. To evaluate the overall ability
of docking/scoring programs to reproduce experimentally determined binding mode, we
implemented volume under the surface (VUS) metric to describe overall performance of pose
reproduction. VUS was calculated as the sum of the volume of all triangular prisms under this
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surface. Briefly, a series of coordinates were obtained based on their RMSD cutoff (X
dimension), ranking cutoff (Y dimension), and the number (Z dimension) of successfully
reproduced structures satisfying C(x, y). RMSD cutoff had interval of 0.5Å, and that for
ranking was 1. The surface was made by connecting any two adjacent points and then
partitioned into a series of triangles. Any of these triangles and their projections on the XY
plane was used to define the triangular prism unit. Detailed calculation of the volume of each
triangular prism unit and VUS were demonstrated in Appendix 2. The ideal VUS was
calculated as 10(RMSD cutoff)×9(rank cutoff)×56(number of targets).

2.2.4 Evaluation of pose ranking
For each RNA-compound complex, we generated 100 decoys to the corresponding RNA as
we described in 1.2.2. Together with the native pose, we obtained 101 RMSD-docking score
data points for each RNA-ligand pair. For native pose ranking study, we scored these 101
poses using different scoring functions as aforementioned. The ranking of native poses for 56
targets were calculated, and we calculated the recovery curves as the ranking cutoffs (X axis)
against the cumulative number of targets (Y axis) in which the ranking of native pose was
smaller than the ranking cutoff. Meanwhile, spearman’s rank correlation coefficient was used
to evaluate the ranking capability. To make the docking scores positively correlated with
RMSD (the higher the scores, the higher the RMSD), we used the negative value of GOLD
Fitness, ChemScore, ASP and Surflex-dock scores. If a pose was assigned a score with the
absolute value more than 1000 (outliers), this RMSD-score pair will be excluded. The
Spearman’s rank correlation coefficient (ρ) was computed using
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r=

∑ (r
∑ (r
i

i

RMSD ,i

RMSD ,i

avg
avg
− rRMSD
)(rscore ,i − rscore
)

avg
avg 2
− rRMSD
) 2 ∑ i (rscore ,i − rscore
)

, where rRMSD ,i and rscore ,i are the rankings of

the RMSD and score for the pose i, and we took the average of the ranks for tied values.
avg
avg
and rscore
are the average ranks of RMSD and score for 101 poses. We classified the
rRMSD

resulted 56 ρ values (calculated from 56 RNA-ligand complexes) for each scoring function
into three groups based on the widely-used criteria: weak correlation: ρ<0.3, moderate
correlation: 0.3≤ρ<0.5, strong correlation: ρ≥0.5.

2.2.5 Evaluation of virtual screening
Two different targets were assessed, bacterial 16S rRNA A-site (representing open and
flexible binding site, PDB ID: 1J7T [73]) and lysine riboswitch (representing closed and rigid
binding site, PDB ID: 3DIL [74]). We collected 75 known rRNA inhibitors including 34
drug-like small molecules from the Foloppe dataset [2] and 31 aminoglycoside mimetics from
the Zhou dataset [3]. Additionally, we obtained 11 aminoglycoside inhibitors which have the
crystal structures in complex with the bacterial rRNA A-site (1J7T, 1YRJ, 2F4T, 2ET8,
1LC4, 1MWL, 2BE0, 2G5Q, 2ESI, 2PWT and 1BYJ). For virtual screening against lysine
riboswitch, we collected 14 compounds including 7 known inhibitors and 7 experimentally
validated inactives [7]. In order to avoid artificial enrichment [75], a focused library
containing 942 drug-like and positively charged decoys was generated from MayBridge
database. We assumed this randomly constructed decoy library does not include or include
very few active compounds as previous studies did. The area under the curve (AUC) for the
receiver operating characteristic (ROC) curve was used to assess the virtual screening
enrichment.
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2.2.6 Evaluation of docking score-binding affinity correlation
The Pearson correlation coefficients (R2) between these docking scores and their
corresponding binding affinities were calculated. Three common outliers, 1LVJ, 1TOB and
2TOB, were excluded during analysis, as they contained many unfavorable steric clashes in
the NMR structures.

2.2.7 RNA-specific scoring function optimization
The weak correlation between docking score and binding affinity might be because most of
the current scoring functions were derived from protein-ligand complexes. To implement
RNA-specific scoring function, we optimized the energetic coefficients in AutoDock4.1
scoring function using dataset provided in Table 2.2. This empirical scoring function was
shown as Equation (2). The parameters (A, B, C, D, S, V) were obtained from default
AutoDock4 scoring function [64]. We optimized the coefficients, WvdW, Whbond, Welec, Wsol and
Wtors using multiple linear regression.

−
 Aij Bij 
 Cij Dij 
qi q j
D=
Gbind Wvdw ∑  12 − 6  + Whbond ∑ξ ( t )  12 − 10  + Welec ∑
+ Wsol ∑ ( SiV j + S jVi ) e 2s + Wtors N tors

r
rij 
rij 
i , j  rij
i ,?j
i j e ( rij ) rij
i, j
 ij
2

rij

2

Besides R2, we calculated leave-one-out (LOO) cross-validation correlation coefficients (Q2)
and validated against an external test set consisting of eight complexes to evaluate the
predictive power of our new scoring function.
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2.2.8 MD simulations of GA:UU RNA-inhibitor complex
All simulation systems were set up using GROMACS 5.05 [76], using a similar protocol
published previously [77]. The topology and charges of inhibitors were prepared using
Gaussian09 at B3LYP/6-311++G(d,p) level of theory on Texas Advanced Computing Center
(TACC). We used ff99bsc0 force field [78, 79] for RNA and general AMBER force field
(GAFF) for inhibitor, prepared by ACPYPE [80]. The RNA-inhibitor complex was solvated
in TIP3P water and neutralized with sodium ions. The simulation boxes were prepared so that
the no RNA or inhibitor atom was within 14Å away from the edge. The system was
minimized and equilibrated for 2 ns before production runs. The production simulations were
performed for 660 ns, with constant pressure maintained by Berendsen barsostat (1 bar),
constant temperature maintained by Berendsen thermostats (300K), LINCS, smooth particle
mesh Ewald, 10 Å cutoff for short-range interactions, and 2-fs time step for bonded, van der
Waals and short-range Coulomb interactions. Snapshots were taken every 20ps for further
analysis.

2.2.9 Preparation of RNA samples
A total of five RNA constructs were prepared in order to evaluate the binding specificity
(canonical base pairs are italic characters):
'

RNA1 (wildtype): 5' GGGCUGUGAUGCUU�
3 CCCGACUAUACGGC
'

RNA2 (miR-328): 5' GGGUGGUGGAUUUU�
3 CCCACUUACUAAGC
'

RNA3 (mutU5A): 5' GGGCAGUGAUGCUU�
3 CCCGACUAUACGGC
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'

RNA4 (mutU5A-ΔAU): 5' GGGCAGUGAGCUU�
3 CCCGACUAUCGGC
'
5 GGAUACCCUGUACUU
�
RNA5 (miR-10b): '
3 CCUAAGGGG-AUGGC

These RNAs were prepared by in vitro transcription with T7 RNA polymerase either
unlabeled or 13C/15N -labeled 5’-NTPs (nucleoside triphosphates), and purified using the
standard protocol described previously [81]. The integrity of the RNA molecules was
evaluated using denaturing PAGE.

2.2.10 Nuclear magnetic resonance (NMR)
Spectrums of the RNA and the DMSO (solvent) were used as controls. All NMR spectra were
acquired on Varian Inova 600 and 800 MHz spectrometers equipped with cryogenically
cooled 1H-[13C, 15N] probes and solvent suppression was achieved using binomial read pulses,
as previously described [81]. 2D 13C-1H HSQC (Heteronuclear Single Quantum Coherence)
spectra were collected to identify 13C-1H chemical shifts. NMR spectra were processed and
analyzed by Felix 2007 (Felix NMR Inc., San Diego, CA). Peaks in the samples with the
RNA and small molecules were compared to the control spectra to predict RNA-compound
interactions.

2.3 Results: Benchmarking and optimizing docking method for RNA target
2.3.1 GOLD:GOLD Fitness and rDock:rDock_solv are the best pose generators
We first benchmarked the docking and scoring combinations for their ability to reproduce the
ligand binding pose similar to the experimentally determined binding mode. An ideal RNA
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docking method should be able to perform a thorough conformational sampling and identify
at least one near-native pose. Table 2.3 showed that, if we arbitrarily employed C(5, 3.0) (the
top 5 pose includes at least one near-native pose with RMSD<3.0Å) to define a successful
docking case, GOLD:GOLD Fitness and rDock:rDock_solv outperformed other methods,
both with 73.21% success rate. Additionally, GOLD:ChemScore, GOLD:ASP,
Glide:GlideScore(SP), Glide:Emodel(SP) and rDock:rDock obtained more than 50% docking
success rate. In contrast, the success rates for Glide:GlideScore(XP), Glide:Emodel(XP),
Surflex and AutoDock4.1 (default) were low, ranging from 30.36% to 44.64%. All programs,
especially AutoDock4.1 and Surflex, had weak performance (<60%) on flexible and
extensively-charged aminoglycosides. When more stringent criteria = C(3, 1.5) was used, the
accuracy decreased but GOLD:GOLD Fitness and rDock:rDock_solv remained as the best
methods (>40%). When compared with rDock:rDock_solv, the GOLD:GOLD Fitness
achieved better performance for the pose reproduction on aminoglycosides-RNA complexes
such as 1J7T, 2FCZ, 2BE0, 1NEM and 2TOB, whereas rDock:rDock_solv produced more
accurate binding modes for drug-like ligand such as 2Z74, 2Z75, 1EHT and 1AKX. The
detailed results (scores, RMSD and statistics) are available from
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869234.

To better demonstrate the relationship between the pose reproduction accuracy and RMSD or
ranking, we illustrated our results with Fig. 2.2A, in which the heavy-atom RMSD and the
ranking of pose were considered simultaneously. VUS represents the overall ability of
reproducing near-native binding modes. It showed that GOLD:GOLD Fitness achieved the
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best VUS (78.11%), while rDock:rDock_solv was the second best (Table 2.3 and Fig. 2.2A).
We proposed to employ the contour of 50% success rate to guide the pose selection in RNA
docking: if one aims to cover at least one near-native pose (RMSD<3.0Å) with 50%
probablity, at least top five poses should be kept when using GOLD:GOLD Fitness. In
contrast, we should keep at least top 20 poses to achieve 50% success for Surflex and
AutoDock 4.1 (Fig. 2.2B). From these assessments, we suggest that GOLD:GOLD Fitness
and rDock:rDock_solv be the best methods for pose reproduction in RNA small molecule
docking.

As expected, we observed that the average docking accuracy on crystal structures was higher
than that on NMR structures for all of 11 current docking/scoring combinations (58.84%
versus 42.27%, p = 0.06). Not surprisingly, the pose reproduction performance on smallmolecule RNA ligands was remarkably better than that on flexible aminoglycosides (64.55%
versus 39.51%, p<0.01). Among the failed cases (defined as two or less docking programs are
able to satisfy C(5, 3.0)), five are crystal structures (2O3V, 2BE0, 2FD0, 2PWT and 2Z75)
and seven are NMR structures (1UUD, 1LVJ, 1TOB, 1AKX, 1EI2, 1KOD and 1QD3). We
found that the current methods were usually less accurate on RNA complexes containing
large aminoglycosides (e.g. lividomycin, paromomycin, etc.), weak RNA binders (e.g.
arginine and citrulline), or phosphate-containing hydrophilic ligands (glucosamine 6phosphate). As negatively-charged moieties can form specific interactions with RNA
phosphates in the presence of metal ions acting as the “metal bridge”, such as 2GDI and
2Z74, we tried docking with consideration of metal ions. As expected, we could significantly
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improve the pose prediction of the diphosphate tail of thiamine diphosphate in 2GDI when the
Mg2+ ion was taken into account as part of RNA targets.
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16 (9)
13 (8)
4 (2)
17 (10)
30.36 (17.86)
43.3
0.22

21 (13)

17 (11)

8 (4)

25 (15)

44.64 (26.79)

55.22

0.05
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rDock

13 (6)

21 (13)

24 (16)

10 (3)

34 (19)

60.71 (33.93)

63.09

0.15

rDock_solv

16 (8)

25 (15)

29 (17)

12 (6)

41 (23)

73.21 (41.07)

73.13

0.18

NA

NA

33.93 (23.21)

19 (13)

7 (5)

12 (8)

15 (11)

4 (2)

Emodel (XP)

1 (1)

4 (2)

rDock 2006.2

Autodock4.1
Score

AutoDock 4.1

Surflex-dock
Score

Surflex 2.415

13 (3)
17 (10)
26 (13)
4 (0)
30 (13)
53.57 (23.21)
65.48
0.03

15 (9)
22 (15)
29 (21)
8 (3)
37 (24)
66.07 (42.86)
70.17
0.29

NA

NA

35.71 (23.21)

20 (13)

8 (5)

12 (8)

16 (11)

4 (2)

GlideScore (XP)

0.14

66.01

55.36 (28.57)

31 (16)

10 (7)

21 (9)

18 (13)

13 (3)

Emodel (SP)

Glide 5.6

ChemScore

ASP

GOLD 5.0.1

0.1

65.41

53.57 (28.57)

30 (16)

10 (7)

20 (9)

18 (13)

12 (3)

GlideScore (SP)

0.25

78.11

73.21 (42.86)

41 (24)

12 (5)

29 (19)

23 (15)

18 (9)

GOLD Fitness

VUS %
Score-binding affinity
correlation R2

Overall Success Rate %

Total [56]

NMR [20]

X-ray crystal [36]

Small Molecule [30]

Aminoglycoside [26]

Scoring function

Docking program

VUS %
Score-binding affinity
correlation R2

Overall Success Rate %

Total [56]

NMR [20]

X-ray crystal [36]

Small Molecule [30]

Aminoglycoside [26]

Scoring function

Docking program

Table 2.3 Performances of binding mode reproduction. 56 RNA-ligand complexes list in
Table 2.1 were benchmarked using different docking/scoring combinations. The values in the
brackets indicated the total number of structure complexes in the category. The values before
the parentheses were the results satisfying C(5, 3.0), and the values in the parentheses were
for C(3, 1.5).

Fig. 2.2. Analysis of the binding mode reproduction performance (A). The cumulative
success rate in 3D representation. Only the scoring functions which obtained the highest
VUS for each docking method were selected for illustration. The contour on the XY
(RMSD-Rank) plane represented the 50% (Z=28) success rate (the binding mode can be
reproduced for 50% of RNA-ligand complexes); (B). The 50% success contour (Z=28) for
all available scoring functions (GlideScore (XP) and Emodel (XP) were not included due to
the unavailability of VUS values). (C). The cumulative success rate for 56 RNA-ligand
complexes based on the ranking of X-ray/NMR determined poses against 100 decoys. The
50% success line and the corresponding rankings to achieve 50% success were shown as
dots.
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2.3.2 ASP: best pose selector
Native pose ranking evaluates the ability to differentiate the experimental pose from the
decoy poses for different scoring functions. This was assessed by investigating two metrics:
the ranking of native poses, and the Spearman’s correlation between scores and RMSDs.
Since GOLD:GOLD Fitness outperformed other docking programs on the coverage of the
near-native poses as aforementioned, it was utilized to generate 100 decoys for each complex
hoping to obtain a decoy set with a smooth transition from near-native binding mode to
unfavorable one. We investigated whether a given scoring function could obtain the highest
rankings for experimentally determined poses. Analogous to IC50 (in assessing biological
activity), we used 50% success rate to evaluate the performance of different docking/scoring
methods. As demonstrated in Fig. 2.2C, the 50% success rate line (dashed) clustered scoring
functions into three groups: ASP, ChemScore, AutoDock4.1 Score and Emodel (SP) were the
first group; the second group included other scoring functions, except rDock which ranked the
lowest as the 3rd group. Fig. 2.2C indicated that GOLD Fitness has 50% of possibility to rank
the native ligand conformation within top 10% of the predicted poses, whereas for ASP,
ChemScore, AutoDock4.1 Score and Emodel (SP), this value reduced to top 5%. The native
pose ranking performance for different docking/scoring schemes varied with different types
of RNA structure. For example, most programs performed significantly better for crystal
structures than NMR structures (69.14% versus 38.89%, p < 0.01) with the top 10 as the
cutoff to define a successful ranking case. Surprisingly, ASP was remarkably better in crystal
structure ranking, in which only two targets (2O3V and 3DIL) failed, while AutoDock4.1
outperformed others on ranking NMR structures. Taken together, these data suggested that
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RNA targets with different structural resolutions should be rescored with respective
appropriate scoring functions (e.g., ASP or AutoDock4.1) after the initial step of docking with
GOLD:GOLD Fitness or rDock:rDock_solv.

For score-RMSD correlation study, we grouped the performances for 56 cases based on the
strength of correlation for each scoring function. Consequently, ASP, GlideScore (SP) and
Emodel (SP) were the best three scoring functions which had most cases with moderate or
strong correlations (Table 2.4). rDock, rDock_solv and Surflex-dock scores obtained fair
performance, which could derive weak or strong correlations for more than 1/3 of cases.
Surprisingly, GOLD Fitness could not achieve satisfactory performance to enrich the nearnative ligand conformations (44 cases obtained the weak correlations) (Table 2.4). Combined
with the native pose ranking analysis, these results demonstrated that other scoring functions
such as ASP could enrich the near-native poses when applied to decoy poses generated by
GOLD:GOLD Fitness.
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Table 2.4. Score-RMSD Spearman’s rank correlations. The values indicated the number
of RNA-ligand complexes fit in each correlation category (Weak: ρ<0.3, Moderate:
0.3≤ρ<0.5, Strong: ρ≥0.5). Top 3 scoring functions are in bold.

Weak
GOLD Fitness
44
ChemScore
41
33
ASP
31
GlideScore (SP)
29
Emodel (SP)
Surflex-dock Score 38
AutoDock4.1 Score 40
rDock
35
rDock_solv
36
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Moderate
5
7
15
15
14
12
5
12
12

Strong
7
8
8
10
13
6
11
9
8

2.3.3 ASP rescoring improves the pose generation
As we have identified ASP as the most robust scoring function for pose ranking, we validate
whether rescoring with ASP is able to improve the identification of near-native binding poses
generated by GOLD:GOLD Fitness or rDock:rDock_solv without artificial parameters
designed for decoy generation. Fig. 2.3 showed the average RMSD-ranking relationship of
ASP rescoring based on GOLD:GOLD fitness or rDock:rDock_solv predicted poses.
Obviously, after ASP rescoring, low-RMSD poses were more likely to appear in top tiers (top
5) compared with using either GOLD:GOLD fitness or rDock:rDock_solv alone. For
GOLD:GOLD fitness, the number of complexes satisfying C(5, 3.0) increased from 41 to 44,
while this number for C(3, 1.5) increased from 24 to 30, compared to original GOLD:GOLD
Fitness performance. Specifically, we observed that the best RMSD in top 5-scored docking
conformations of 2GDI, 2Z74, 2PWT and 1ZZ5 was significantly reduced (below 3.0Å) after
ASP rescoring. In contrast, GOLD:GOLD Fitness alone failed to identified the near-native
conformation for these complexes (Fig. 2.4). Furthermore, VUS increased from 78.11% to
79.18%. Compared with the docking accuracy using GOLD:GOLD Fitness alone, the average
RMSD for the top-scored conformations was further reduced to 2.61±0.38Å (Fig. 2.3 (up)).
Similarly, ASP rescoring improved VUS from 73.13% to 75.24% and the average RMSD of
top-scored poses was reduced to 2.92±0.49 Å (Fig. 2.3 (down)). Combined with native pose
ranking and RMSD-score correlation results, our results confirmed that ASP has the best
ability for pose ranking, and ASP rescoring can significantly enrich the near-native poses
generated by GOLD:GOLD Fitness or rDock:rDock_solv for pose reproduction purpose in
RNA-ligand docking.
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Fig. 2.3. ASP rescoring improves the ranking of poses (overall statistics). (Up) ASP
rescoring based on the poses generated by GOLD:GOLD_Fitness (Down) ASP rescoring based
on the poses generated by rDock:rDock_solv.
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Fig. 2.4. ASP rescoring improves the ranking of poses (molecular view). Experimental
structures were in green (RNAs in ribbons, ligands in sticks). Only the docking
conformation with the lowest RMSD selected from the top five-scored poses were shown.
GOLD:GOLD Fitness poses were colored red, while ASP rescored poses are colored
yellow. (A) 2GDI; (B) 2PWT; (C) 2Z74; (D) 1ZZ5.
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2.3.3 Improved score-binding affinity correlation by iMDLScores
Here we benchmarked the score-binding affinity correlation to assess the ability of scoring
function to differentiate the binder against the non-binder. Surprisingly, we found all existing
scoring functions received poor correlations (R2 < 0.3) (Table 2.3 and Fig. 2.5). To improve
the correlation with the experimentally measured binding affinity, we developed new scoring
functions, iMDLScore1 and iMDLScore2, using our RNA-ligand binding free energy datasets
(Table 2.2). This was done by optimizing AutoDock4.1 scoring terms, Wvdw, Whbond, Welec,
Wsol, Wtors, using multi-linear regression (MLR). We derived iMDLScore1 using the full
dataset, in which the contributions of those scoring terms are 0.1460 for vdW, 0.0745 for
hbond, 0.0559 for electrostatic, and 0.3073 for torsions (Table 2.5). iMDLScore1 achieved a
significantly better correlation (R2 = 0.70) between the docking scores and binding affinities.
When iMDLScore1 was further validated against an external test set consisting of eight
complexes, the R2 = 0.82, and the root-mean-square error (RMSE) of prediction = 4.09kJ/mol
(Fig. 2.6A).

A known challenge in RNA virtual screening is to enrich the actives from a focused library
with positively-charged molecules because most RNA binders are potentially positively
charged. To overcome this problem, we derived a second scoring function, iMDLScore2, with
a dataset containing 18 complexes with only positively charged ligands. For iMDLScore2, the
contribution are 0.1634 (vdW), 0.2436 (hbond), 0.2311 (electrostatic), and 0.2212 (torsion)
(Table 2.5). Interestingly, R2 and Q2 (leave-one-out cross validation R2) for the training set
reached 0.79 and 0.62, and R2 (test set) = 0.76. RMSE of prediction (4.35kJ/mol) was
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comparable to that of iMDLScore1 (Fig. 2.6B). Q2, R2 and RMSE of prediction indicated the
better predictive power of RNA-ligand binding affinities by both iMDLScore1 and
iMDLScore2, compared with any other existing scoring functions.
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Fig. 2.5. Binding free energies-score correlation for ASP, GOLD_Fitness, AutoDock4.1
Score (default). Three outliers, 1TOB, 2TOB and 1LVJ, were highlighted in rectangles.
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Fig. 2.6. Score-binding affinity correlation for iMDLScores. (A) iMDLScore1. (B)
iMDLScore2.
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Table 2.5. Contributions of AutoDock energetic terms and associated performances in
binding affinity correlation study.
Parameter
vdW
hbond
electrostatic
desolvation
torsion
No. of complexes as training set
R2 (training set)
LOO Q2 (training set)
R2 (test set)
RMSE of prediction (kJ/mol, test set)

Default
0.1662
0.1209
0.1406
0.1322
0.2983
NA
0.22
NA
NA
NA
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iMDLScore1
0.146
0.07451
0.05593
0
0.3073
25
0.70
0.44
0.82
4.09

iMDLScore2
0.1634
0.2436
0.2311
0
0.2212
18
0.79
0.62
0.76
4.35

2.3.4 Novel three-step virtual screening scheme improves the enrichment
Our ultimate goal is to identify an optimal pipeline for vHTS against RNA targets. In our
benchmark, the ROC AUCs for Foloppe dataset are around 0.6 for both GOLD:GOLD fitness
and rDock:rDock_solv, whereas the ROC AUCs for lysine riboswitch decoys are 0.82 and
0.86 for GOLD:GOLD fitness and rDock:rDock_solv, respectively (Table 2.6). As expected,
three-step virtual screening, namely docking – rescoring (poses) – rescoring (compounds),
could significantly improve the virtual screening enrichment in both cases. For Foloppe
dataset, the enrichment was significantly increased by rescoring either rDock:rDock_solv or
GOLD:GOLD Fitness generated poses using iMDLScore2 (AUC=0.74 and 0.69, compared
with 0.61 and 0.58 without rescoring) (Fig. 2.7). For lysine riboswitch, however, all
AutoDock-related could not obtain as good AUC (AUC <0.85) as other rescoring schemes
(AUC>0.95) (Table 2.6). Additionally, we investigated whether any rescoring scheme could
improve the differentiation of the seven known lysine riboswitch inhibitors from the seven
experimentally validated lysine-analog decoys (more challenging due to the chemical
similarity between actives and inactives). We found that GOLD:GOLD_Fitness combined
with rDock_solv rescoring achieved the best enrichment (AUC=0.86) (Fig. 2.7) and ranked
all seven active compounds within top eight.

We are surprised to find that the optimal combination of the methods for these two targets is
different. We hypothesize that it was due to distinctive flexibility of the binding site. Bfactors analyses of active site of 16S rRNA A-site were statistically higher than other part of
the RNA (p=0.002) (Fig 1.8A), indicating that rRNA A-site is a flexible target. Furthermore,
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normal mode analysis using oGNM [82] confirmed this local flexibility (Fig. 2.8B), because
significant fluctuation of the A-site residues could be observed within five lowest-frequency
modes (low-frequency motions are expected to have larger contribution to the conformational
changes [83]). In contrast, based on the crystal structure of lysine riboswitch, the ligand
(lysine) is completely enveloped in the rigid binding pocket of lysine riboswitch, and only the
small molecules which can sterically fit the pocket can be accommodated. B-factor analysis
demonstrated that lysine-binding pocket in this riboswitch was statistically more rigid than
other residues (Fig. 2.8A). Normal mode analysis further confirmed the rigidity of this pocket
(Fig. 2.8C).
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Fig. 2.7. ROC curves of the virtual screening experiments. (A). Virtual screening against the
16S rRNA A-site using the Foloppe dataset. (B). Virtual screening against the lysine riboswitch
using 7 known active compounds. (C-D). ROC comparison of the virtual screening performances
of AutoDock4.1 and iMDLScore1/iMDLScore2 scoring functions with rRNA A-site (C). and
lysine riboswitch (D). GOLD:GOLD Fitness dockings were in thin lines, while rDock:rDock_solv
dockings were in thick lines. AutoDock4.1 default scoring function, iMDLScore1 and
iMDLScore2 were colored red, blue and black, respectively.
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Aminoglycosi
des 1
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dataset 1
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Zhou
dataset 1

Bacterial rRNA A-site (1J7T)

Lysine riboswitch (3DIL)

iMDLScore2

rDock:rDock_solv

rDock:rDock_solv

rDock:rDock_solv

AutoDock4.1
Score
iMDLScore1

GOLD:GOLD Fitness
iMDLScore2

GOLD:GOLD Fitness

GOLD:GOLD Fitness

AutoDock4.1
Score
iMDLScore1

GOLD:GOLD Fitness

GOLD:GOLD Fitness

rDock:rDock_solv

GOLD:GOLD Fitness

Initial docking &
scoring function

rDock_solv

ASP

None

None

Rescoring function

Table 2.6. ROC AUC for various docking and scoring combinations in virtual screening.

Fig. 2.8. Difference between flexible and rigid RNA targets. (A) B-factor distribution. (B)
Predicted flexibility of 16S rRNA A-site based on normal mode analysis. (C) Predicted
flexibility profile of lysine riboswitch based on normal model analysis.
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Fig. 2.9. The suggested workflow for structure-based virtual screening for RNA-targeted
inhibitor discovery.
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2.4 Results: Application of three-step docking scheme to identify novel RNA-small
molecule interaction
2.4.1 Identify small molecules that binds GA:UU RNA internal loop
To identify the potential binders for GA:UU internal loop, we performed in silico highthroughput virtual screening using the protocol we derived in Chapter 1.3. Specifically, we
screened ChemBridge diverse set (containing 100,000 compounds) and MayBridge
(containing 14,400 compounds) using “GOLD:GOLD_Fitness-ASP-rDock_solv” pipeline for
an NMR ensemble containing GA:UU motif provided by Dr. Nikonowicz group. Upon
clustering analysis and visualization of the molecular interaction, we selected 15 compounds
for experimental evaluations using 1D and 2D NMR. 1D NMR confirmed that two out of 15
compounds (compound 423 and 449) are able to affect the chemical shifts for GA:UU motif.
Compound 423 contains an amino-benzothiazole scaffold, whereas compound 449 contains a
1,4-dihydroquinoxaline-2,3-dione moiety. The chemical structure of 449 is shown in Fig.
2.10.

2.4.2 Experimental validation by NMR
The 1D imino proton resonances reflect the presence or absence of the RNA base pairing.
Using 1D NH NMR, we identified 2-amino-1,3-benzothiazole-6-carboxamide (compound
423) as the most potent and selective compound. The imino spectra of U22 and U7, which
form noncanonical base pair in the unbound structure, exhibit weaker chemical shift and
selective broadening by the addition of compound 423. Meanwhile, some chemical shifts
from a G-C base pair (~12.7ppm) and A-U base pair (~13.2ppm) were displaced (Fig. 2.10A46

B). However, the addition of compound 423 did not perturb the NH spectrum of a control
RNA (RNA5: pre-miR-10b) that does not contain GA:UU motif (Fig. 2.10D-E). This result
demonstrates that compound 423 does discriminate bulge / mismatch nucleotide identity.
Although this does not indicate 423 is specific for the GA:UU motif, these results
demonstrate this compound does discriminate bulge/mismatch nucleotide identity. In
comparison, compound 449 shows a weaker effect on the 1D NH spectra (Fig. 2.10C).

According to 2D 13C-1H HSQC spectrum, the addition of compound 423 abolishes the
chemical shifts from U7H6, G8H1’, A9H8, A9H2, and the chemical shift from G8H8
becomes weak (Fig. 2.11). Chemical shift from U7H1’ is also altered (Fig. 2.11). The peak
perturbations in the NH and base spectra indicate that the binding of compound 423 should
occur in the GA:UU tandem mismatch motif, but most of the effects are caused by the
binding of G8 and A9. To further explore the binding context, 2D NMR was performed on 3
variants. The first one has GU wobble base pair at UU side and GC base pair at GA side

(RNA2:

5' GUGG3'
), whereas the 2nd and 3rd variants extends the UU side with a AA:AU
3'UUAC 5'

motif (RNA3:

molecule (

5' AGUGAU 3'
5' AGUGAG3'
, RNA4:
). Compared with the original RNA
3' ACUAUA5'
3' ACUAUC 5'

5'UGUGAU 3'
), RNA2 is much less stable at UU side (flanked by GU base pair)
3' ACUAUA5'

and more stable at GA side (flanked by GC base pair). RNA3 is less stable at UU side
(flanked by GC+AA base pair), whereas RNA4 is more stable at GA side (flanked by
AU+GC base pair). Consequently, we observed changes on RNA3, but not RNA4 and RNA5
using 13C-1H HSQC spectra (Fig. 2.11B-C). In fact, the effects on NMR spectra demonstrated
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inverse correlation with the rigidity at GA side (rigidity at GA side: RNA2 > RNA4 > RNA1
& RNA3). This suggested that the flexibility adjacent to the GA base pair be another attribute
that determines the selectivity of 423.
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Fig. 2.10. 1D NH spectra. of the GA:UU mismatch (A-C) and pre-miR-10b RNA
hairpins (D,E). (A,D) RNA (0.015 mM) in 5% DMSO, (B,E) with 2-amino-1,3benzothiazole-6-carboxamide (1), and (C) 5,7-dimethyl-1,4-dihydro-2,3quinoxalinedione (2). Peaks altered by the compounds are labeled (*). 423 interacts with
GA:UU mismatches but not A-A or bulged G. The interaction of compound 449 is
weaker. Compound concentrations are 0.1 mM. NH spectrum is unaffected by 5%
DMSO.
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Fig. 2.11. 2D 1H-13C spectrum. Base region of 2D 1H-13C spectrum of GA:UU containing
RNA molecule (black). The spectrum after addition of compound 423 (red) leads to exchange
broadening of labeled peaks. (A) RNA1(wildtype). (B) RNA3(mutU5A). (C) RNA4
(mutU5A-ΔAU).

A

B

C
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2.4.3 Molecular dynamics study
To further investigate the selective binding mechanisms of 423 to GA:UU RNA internal loop,
intensive MD simulations (~660 ns) were performed. Fig. 2.12A showed the smoothed
trajectory of compound 423 over a total of 660 ns simulation in the explicit solvent.
Intriguingly, we observed a complete binding circle of 423’s associating or dissociating with
GA:UU motif (Fig. 2.12A-B), indicating that the MD simulation we performed has sampled
adequate configurational spaces and could be employed as a structural ensemble for further
analysis. Based on MD simulation, we observed six periods in which compound 423 formed
stable binding to RNA (Fig. 2.12C). Starting from the docking conformation, the 423 quickly
associated with the minor groove of GA:UU motif (center of mass (COM) distance between
GA:UU and 423 = 10Å) and formed specific and stable binding for ~100 ns (molecular
details will be discussed later). Then 423 disassociated from GA:UU motif to the bulk
solvent, and form nonspecific stacking with RNA terminal nucleotides periodically (at 150ns,
230ns, 300ns respectively). Compound 423 also interacted with the major groove formed by
GA:UU motif in a nonspecific and transient manner (at ~450ns). Finally, it traveled back to
the minor groove of GA:UU motif, in which the binding mode is almost identical to that in
Stage I (COM distance = 8.2Å). After binding specifically to GA:UU for ~80ns, 423 once
again disassociated from the RNA molecule and began a second binding circle (Fig. 2.12C).

Further examination of the average 3D model from Stage I and VI revealed that compound
423 primarily bind to the minor groove formed by G8, A9, U20, A21 (Fig. 2.13A) The
benzothiazole moiety formed aromatic stacking on A21, and the amine group interacted with
51

U20 through intermolecular H-bond (Fig. 2.13A and Fig. 2.13C). Moreover, the sheared GA
base pair exhibited an out-of-plane conformation (propeller twist) by 40° after the addition of
423 (Fig. 2.13A). Compared with the unbound structure (Fig. 2.13B and Fig. 2.13D), we
observed that (1) A9H2 and G8H1’ directly interact with 423 which explains the missing
chemical shifts seen in the unbound RNA; (2) Due to the conformational changes caused by
GA base pair propeller-twist, G8H8 and A9H8 changed their chemical environment; (3) The
chemical shift changes of U7H6 and U7H1’ is likely due to the change of sugar puckering of
G6 (arrow highlighted in Fig. 2.13C-D). These findings are all consistent to 2D 13C-1H HSQC
spectra. Moreover, Fig. 2.14 demonstrated that destabilizing the two base pairs next to GA
side is an essential step before compound 423 binds to GA:UU motif. In comparison, the base
pair stability at +3 position (Fig. 2.14 (bottom)) does not correlate with the compound
binding event. Therefore, MD simulation confirms the RNA specificity we observed in
Chapter 1.4.2 that the flexibility at GA side may enhance the binding affinity.

2.4.4 Structure-activity relationship (SAR) analysis
Based on this 3D structural model, we further validated our hypothesis using rational
designed structure-activity relationship (SAR) study. SAR demonstrated that any substitution
on the R1, R2 or R3 group failed to show any changes in the NMR spectra at concentration as
high as 0.2mM (Table 2.7). This SAR result was consistent to the 3D model predicted by MD
simulation, in which the amine group forms H-bond with U20, and the R3-carboxamide forms
polar contacts with G8 ribose ring such that any hydrophobic substitution is likely to abolish
the binding. NMR proved that moving R3-carboxamide to R2 position is also detrimental, as
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indicated by the 3D model that R2 is exposed to the solvent and has minimal contribution to
the binding (Fig. 2.13A).
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Fig. 2.12. MD simulations of compound 423 binding to GA:UU motif. (A) Smoothed
trajectory of GA:UU RNA and compound 423 over 660ns simulation. The color ranges from
red to blue, denoting the time-dependent evolution of the complex structure from 0ns to
660ns. (B) Representative structures of through MD simulation. (C) Center of mass distance
between GA:UU and compound 423. Each stable state is assigned an ID, whose 3D structure
has been illustrated in (B).
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Fig. 2.13. 3D model of compound 423 binding to UU:GA motif. Compound 423 are
shown in red sticks, and the atoms altered by addition of 423 are shown in sphere. The
changes of sugar puckering are highlighted with arrows. (A) Minor groove view of 423bound structure. (B) Minor groove view of unbound structure. (C) Major groove view of
423-bound structure. (D) Major groove view of unbound structure.
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Fig. 2.14. Base pair flexibility of the context of GA:UU motif. Time-dependent
distance between A9N1-U20N3, U10N3-A19N1, and G9N1-C18N3, which denote the
three base pair from the GA base pair. The arrows highlighted the time point that 423
start to associate with GA:UU motif.
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Table 2.7. Structure-activity relationship of 423 series compounds.
R1
-H
-H
-H
-H
-NH2

R2
-H
-H
-H
-CONHNH2
-H

R3

Activity
-CONH2
active
-NHCOCH3
inactive
-CH(CH3)CH2-423 inactive
-H
inactive
-CONHNH2
inactive
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2.5 Discussion
RNA represents a historically important, but less systematically investigated therapeutic
target. The discovery of various aminoglycosides inhibitors target prokaryotic 16S rRNA is a
proof-of-principle that RNA can be specifically targeted by small molecules. On the other
hand, rational design of small-molecule inhibitor targeting specific RNA motif less
appreciated due to lack of reliable in silico tools for structure-based drug design. To address
this issue, we have benchmarked and identified an optimal docking / scoring pipeline for
RNA-ligand modeling and virtual screening through a comprehensive evaluation in three
different aspects. First, we have identified GOLD:GOLD Fitness and rDock:rDock_solv as
the best pose predictors and are most appropriate for the initial binding modes generation.
Nevertheless, we proved that rescoring of the predicted binding modes is a necessary step to
enhance the enrichment of true positives in virtual screening exercises. To this end, we
discovered that ASP, rather than GOLD Fitness or rDock_solv scoring function, achieved the
best performance in pose ranking evaluation. Second, scoring functions can be generally
classified as soft-core potentials (e.g. AutoDock scores and iMDLScores) and hard-core
potentials (rDock_solv and ASP). Based on the structural resolution and flexibility of the
binding sites, hard- or soft-core potentials may behave distinctively, as we summarized in
Fig. 2.9. Hard-core scoring functions, for example, usually result in better ROC AUC than the
soft-core ones when the target is an RNA ensemble. Third, implementation of RNA-specific
scoring function (e.g. iMDLScore2) improved the virtual screening enrichment as well as the
accuracy of RNA-ligand binding affinity prediction.
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In agreement with previous docking benchmarks [84], we report that the docking/scoring
combination that is specialized in binding mode reproduction does not correlate its
corresponding performance in virtual screening. Hence, we exhaustively explored the best
strategy independently for pose generation, pose ranking and hit ranking, so called three-step
RNA virtual screening. Consistent to our hypothesis, some scoring function such as
iMDLScore2 which is good at hit identification (the final step) performs poorly in initial pose
generation (the first step). We found that if iMDLScore2 was biased to the electrostatic
interactions with RNA backbone if it was selected for pose generation (Fig. 2.15). Indeed, we
concluded that so far no existing docking/scoring combination can have satisfactory
performances on all three steps. Our three-step pipeline circumvented the pitfalls of
traditional one-step docking-scoring by separating the conformation-wise pose
generation/selection and ligand-wise hit selection, and it outperformed other methods in our
virtual screening benchmarks (Fig. 2.7).
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Fig. 2.15. Comparisons of AutoDock4.1:iMDLScore2 predicted binding modes
with experimental structures. 1NTB, 2ESI and 3DIL were used as the examples to
demonstrate the overestimation of polar interactions with RNA phosphate for initial
pose generation purpose. RNA receptors were shown in green lines, while
experimentally determined binding modes are shown in cyan sticks. AutoDock4.1
generated pose with the best RMSD were in orange sticks. The interactions between
basic guanidinium/amine groups with RNA atoms were labeled with magenta dashes.
We could observe that these basic groups were predicted dominantly to form
interaction with the backbone phosphates; actually, the H-bonds with RNA base
atoms and cation-π interactions were more favorable.
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Compared with one-step docking process, one of the limitations of our three-step pipeline is
that current implementation cannot derive a statistical model of determining how many
candidates we should retain for the next step. Here we conceptualized a successful virtual
screening exercise as a process not only to cover the near-native ligand conformation, but also
to enrich the true positive from these predicted conformations. Hence, the hit rate is a net
effect of pose selection and compound selection, and we observed that forwarding too many
poses for each ligand to hit selection stage may harm the virtual screening performance. Fig.
2.16 showed that keeping top three poses in GOLD:GOLD Fitness phase achieved the best
ROC AUC in iMDLScore2 rescoring phase. ROC AUC is declining when no. retained poses
is increasing. Similar trend is also found when rDock:rDock_solv is used as the first phase,
but the maximum performance occurs only when we retains top 6 poses. Our data suggest that
even though arbitrarily keeping top 10 poses can only compromise <3% ROC AUC, the
number of poses that can achieve the best performance is still hard to estimate a priori. Thus,
we will continue to develop statistical model to predict the a priori no. of poses based on the
features of target and screening library.
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Fig. 2.16. ROC AUC against number of candidate poses selected for iMDLScore2
rescoring for 16S rRNA A-site. The downward-pointing triangle (▼) represents the
number of picked poses corresponding to the best ROC AUC (turning point).
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Chapter 3: Computational modeling of novel RNA-protein interaction
3.1 Introduction
All aforementioned pitfalls described in Chapter 1.2 motivated the implementation of
interface threading for RPI prediction. The idea of interface threading is inspired by iWRAP
[85] which predicts protein-protein interaction (PPI) by referencing to template PPI(s). Our
implementation, RPI prediction through Interface Threading (or RPIT), identifies and
references an RNA-protein interface as a template to estimate the interface region where the
interaction occurs. To estimate the interaction propensity between different types of amino
acids and nucleotides more precisely, we have implemented a set of statistical scoring
functions based on our unique collection of non-redundant protein-RNA interaction database.
Compared with sequence-based methods, interface threading model not only predicts
accurately the probability of the RNA-protein direct binding, but also infers the sequence
elements that are most attributable to binding. This is significantly appealing when the size of
RNA (or protein) is huge so that trivial mutagenesis study is prohibitive when validating the
computational model. Compared with structure-based method, RPIT offers an inexpensive but
robust method for in silico prediction of RNA-protein interaction networks, and for
prioritizing putative RNA-protein pairs for experimental validation.

Here we hypothesized that the interaction propensity between protein and RNA is dominated
by interface regions, and mutations on a distal region contribute less than those close to the
interface. In order to validate this hypothesis, there are four specific aims (Fig. 3.1):
1. Develop an interface template database to which query protein-pair can thread.
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2. Develop statistical scoring functions to evaluate the threading performance.
3. Design novel alignment (threading) paradigms to incorporate 2nd structural and
interface importance information.
4. Implement classifier to predict the probability of interaction based on alignment
and scoring functions.
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Fig. 3.1. An overview of protein-RNA interface threading pipeline. There are four
milestones of protein-RNA interface threading. 1. Develop an interface template database. 2.
Develop statistical scoring functions. 3. Design alignment (threading) algorithms. 4.
Implement functions to predict the probability of interaction based on alignment and scoring.
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3.2 Materials and Methods: Development, Validation and Application
3.3.1 Non-redundant protein-RNA interfaces database (nrPR)
As of April 26th 2014, there are totally 1,585 protein-RNA complex structures deposited in
PDB. From this collection, we have curated 20,111 protein-RNA interaction pairs (termed as
totPR dataset), each of which contains at least five residue-based intermolecular interactions.
We further removed the redundants from totPR (using 0.8 similarity cutoff for protein and 0.6
for RNA, considering sequence, secondary structure and types of interaction simultaneously),
ultimately resulting in 5,471 non-redundant interaction pair (termed as nrPR database). This
nrPR database will be used as the threading templates as well as the training set to derive
statistical scoring functions. Notably, we keep the non-standard amino acids and nucleotide
intact in the 3D structure, but may ignore them when deriving statistical scoring functions.
For NMR structures, we select the best representative model according to ‘selection_criteria’
tag in the mmCIF file. The diversity of the protein or RNA sequences in nrPR is analyzed by
principle component analysis (PCA) using conjoint triad descriptors [59]. There are 343
features for protein sequence and 256 features for RNA sequence. In this chapter, we may use
“query” and “target” interchangeably.

3.3.2 Statistical Scoring Functions
We designed five knowledge-based statistical scoring functions to determine the fitness of
interface threading. Generally, PInter (or RInter) estimates the interaction propensity that
evaluates how favorable an interfacial protein (or RNA) residue to form a specific interaction.
PDist (or RDist) estimates the distance propensity that evaluates how favorable a protein (or
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RNA) residue is found on/close to the interface. Here we defined 12 types of RPI which
empirically summarize the fundamental amino acid-nucleotide contacts at atomic level
(Table 3.1). Fig. 3.2 illustrates the schematic view of these 12 types of interaction.

The secondary structure of protein residues were analyzed by Stride [86]. As Stride predicts 7
types of protein secondary structures (H=α-helix, G=310-helix, I=π-helix, E=extended
conformation, B(or b)=isolated bridge, T=turn), we clustered these 7 secondary structure
codes into helix, sheet and coil as following: helix ∈ {H, G , I } , sheet ∈ {E , B (b)} ,

coil ∈ {T , C} . RNA secondary structures were analyzed using DSSR v1.0.2, a new
component of 3DNA suite of software programs [87]. We define a paired state to be WatsonCrick base pairing (19-XIX or 20-XX) or G-U wobble base pairing (28-XXVIII), and an
unpaired state to be any other noncanonical base pair or unpaired bulge. vdW interaction
denotes any atom pair with distance shorter than 4.0Å. Salt bridge (or electrostatic attraction)
denotes the interaction involving a phosphate atom of nucleotide and an atom of basic amino
acid whose distance is shorter than 4.5Å. All H-bonds, aromatic stacking, cation-π
interactions, and electrostatic attractions were computed by Molecular Operating
Environment (MOE). Then we confirmed the MOE assignments and assign aromatic-like
stacking and hydrophobic stacking using the criteria described in Table 3.1, based on the
number of atomic contacts.
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N(vdw between protein sidechain and
RNA base) ≥ 12
N(vdw between protein sidechain and
RNA base) ≥ 3
N(vdw between positively charged
protein sidechain and RNA base) ≥ 3 a

D, N, E, Q, R

A, V, P, I, L, M

K, R
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N(H-bond with protein sidechain) ≥ 1 a
N(H-bond with RNA backbone) ≥ 1 a
N(H-bond with protein backbone) ≥ 1 a

D, E, H, K, N, Q, R, S, T, W, Y

all

all

a

b

Interaction that are confirmed by MOE
12 interaction types are applicable to all nucleotides

dist(positively charged protein
sidechain, RNA phosphate) < 4.5 Å a

N(H-bond with protein sidechain) ≥ 2 a

D, E, H, K, N, Q, R, S, T, W, Y

K, R

N(H-bond with RNA base) ≥ 1 a

all

N(H-bond with RNA base) ≥ 2 a

N(vdw between protein sidechain and
RNA base) ≥ 12 a

H, F, Y, W

all

dist < 4.0Å a

Definition

all

Applicable amino acids b

basic amino acid interacting with
RNA phosphate (<4.5Å)

at least one H-bond interaction
with protein backbone

at least one H-bond interaction
with RNA backbone

one h-bond interaction with
protein side chain

at least two h-bond interactions
with protein side chain

one h-bond interaction with
RNA base

at least two h-bond interactions
with RNA base

cation-π interaction with RNA
base

hydrophobic stacking with RNA
base

aromatic-like stacking on RNA
base

aromatic stacking on RNA base

van der Waals interaction

Comment

salt

bb_p

bb_r

hbp_1

hbp_2

hbr_1

hbr_2

cpi

hy

arom_l

arom

vdw

Type

Long-range nonspecific

Protein backbone
recognition

RNA backbone
recognition

Protein sequence
recognition

RNA sequence
recognition

Base stacking

General

Category

Table 3.1 Summary of 12 types of RPI

Fig. 3.2. Schematic view of 7 major categories of RPI types.
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3.3.2.1 PInter and PDist: RNA-binding ability for amino acids

PInter scoring function quantifies the probability of a given amino acid (i) holding the
secondary structure (ssk) to form a specific interaction (tm) to any nucleotide. i ∈ 20 standard
amino acids, k ∈ {helix, sheet , coil} , m ∈ 12 interaction types. The statistical potential of
PInter is written as following:



 N obs ( pissk , tm ) 
N obs ( pissk , tm ) + Bc 60


PInter pissk , tm ln=
ln
=


ssk
ss .


N
(
p
,
t
)


X
X
N
(
p
,
t
)
B
⋅
⋅
+
exp
i
m
c 


 i , ssk tm  obs . .
N obs ( pissk )
X i , ssk =
N obs ( p.ss. ∈ Tm )

(

X tm =

)

N obs ( p.ss. , tm )
N obs ( p.ss. , t. )

Bc = N obs ( p.ss. , tm )

N obs ( pissk , tm ) is the observed number of interaction of a protein residue, pissk , with any
ss

nucleotide using interaction type, tm , whereas N exp ( pi k , tm ) is the expected number of
interaction of a protein residue, pissk , with any nucleotide using interaction type, tm . The
expected value is calculated in a similar manner as in χ2-test. Here, we estimates the unbiased
fraction of residue pissk ( X i , ssk ) and type tm ( X tm ) from all observed interactions (

N obs ( p.ss. , t. ) ), in which dot ‘.’ denotes any residue, secondary structure or interaction type.
To take zero observation N obs ( pissk , tm ) into consideration, a pseudocount Bc is added to
both denominator and numerator. Bc is calculated as the square root of all observations

N obs ( p.ss. , t. ) . Of note, when computing the unbiased fraction of protein residue X i , ssk ,
interaction propensity of some interaction type (e.g., aromatic or aromatic-like stacking,
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cation-π) can be inflated, due to the physicochemical nature of different amino acid. For
example, Ala, Val, Leu and Ile by nature are incapable of forming H-bond with its sidechain,
and thus hbp_2 and hbp_1 are not applicable to these residues. Therefore, we apply an
“interaction type correction” when computing the denominator for X i , ssk . N obs ( p.ss. ∈ Tm )
denotes the number of observed amino acid in which the interaction category that tm is
belonged to is applicable. For instance, when calculating interaction propensity of (Phe, αhelix, aromatic stacking (arom)), N obs ( p.ss. ∈ Tm ) will only counts the residues that are able
to form aromatic stacking, aromatic-like stacking, hydrophobic stacking or cation-π
interaction. This can significantly reduce the bias toward amino acid-specific interaction type.

PDist scoring function quantifies the probability of a given amino acid (i) holding the
secondary structure (ssk) to reside at most dθ Å from any interfacial amino acid. i ∈ 20
standard amino acids, k ∈ {helix, sheet , coil} , θ ∈ {02 20} . When the given amino acid
forms direct interaction with RNA (interfacial residue), the distance is zero. The statistical
potential of PDist is written as following:


 N obs ( pissk , d ≤ dθ ) 
N obs ( pissk , d ≤ dθ ) 
=
PDist pissk , dθ
ln=
ln




ssk
 X i , ss ⋅ X d ⋅ N obs ( p.ss. , d. ) 
 N exp ( pi , d ≤ dθ ) 
θ
k


ssk
N (p ,d )
X i , ssk = obs iss. .
N obs ( p. , d. )

(

X dθ

)

N obs ( p.ss. , d ≤ dθ )
=
N obs ( p.ss. , d. )
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Basically, N obs ( pissk , d ≤ dθ ) is the number of observed cases for a specific protein residue

pissk to be found at a distance equal or less than dθ . N exp ( pissk , d ≤ dθ ) is the number of
expected cases for a specific protein residue pissk to be found at a distance equal or less than

dθ .To calculate the expected value, we estimate the unbiased fraction as we did in PInter.
N exp ( pissk , d ≤ dθ ) is computed as the multiplication of unbiased fraction of pissk ( X i , ssk ),
unbiased fraction of all residues with maximal distance to interfacial atom d ≤ dθ ( X dθ ) and
total number of observations for any residue at any distance ( N obs ( p.ss. , d. ) ). Different from
interaction propensity, no pseudocount was applied here, as theoretically the occurrence of
protein residue at some distance is assumed to be random enough to prohibit zero observation.

3.3.2.2 RInter and RDist: Protein-binding ability for nucleotides

RInter scoring function quantifies the probability of a given nucleotide (j) holding the
secondary structure (ssl) to form a specific interaction (tm) to any amino acid. i ∈ 4 standard
nucleotide, k ∈ {WC / GU , others} , m ∈ 12 interaction types. The statistical potential of
RInter is derived as following:



 N obs (rjssl , tm ) 
N obs (rjssl , tm ) + Bc 8


=
RInter r , tm ln=
ln
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.




l
m

N obs (rjssl )
X j , ssl =
N obs (r. ss. )

(

X tm =

ssl
j

)

N obs (r. ss. , tm )
N obs (r. ss. , t. )

Bc = N obs (r. ss. , tm )

72

Here all parameters used in RInter scoring function are similar to those in PInter, except that
1) the pseudocount are divided by 8, because there are only 8 combinations of nucleotide type
and 2 secondary structure type for RNA; 2) there is no interaction type correction when
computing unbiased fraction of nucleotide, X j , ssl , because all 12 interaction types are
applicable to all nucleotides (A, U, G, C).

Similar to protein, we define RDist as following, in which X j , ssl and X dθ are the unbiased
ss

fractions for RNA nucleotide ( rj l ) and the maximal distance from any interface nucleotide (

d ≤ dθ ), respectively:


 N obs (rjssl , d ≤ dθ ) 
N obs (rjssl , d ≤ dθ )
ln=
ln
RDist r , dθ
=




ssl
ss.



 N exp (rj , d ≤ dθ ) 
 X j , ssl ⋅ X dθ ⋅ N obs (r. , d. ) 
N obs (rjssl , d. )
X j , ssl =
N obs (r. ss. , d. )

(

X dθ =

ssl
j

)

N obs (r. ss. , d ≤ dθ )
N obs (r. ss. , d. )

3.3.2.3 Protein-RNA interface fitness: PRInter

PRInter scoring function quantifies the probability of a given amino acid (i) holding the
secondary structure (ssk) to form a specific interaction (tm) to a given nucleotide (j) holding

the secondary structure (ssl). The definitions of i, j, ssk, ssl, tm have been described above. The
statistical potential of PRInter is given as following:
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 N ( p ssk , r ssl , t ) 
PRInter pissk , rjssl , tm = ln  obs issk jssl m 
 N ( p , r ,t ) 
j
m 
 exp i


N obs ( pissk , rjssl , tm ) + Bc 480

= ln 
 X i , ss ⋅ X j , ss ⋅ X t ⋅  N obs ( p.ss. , r. ss. , t. ) + Bc  


k
l
m


(

X i , ssk =
X j , ssl =

)

N obs ( pissk )
N obs ( p.ss. ∈ Tm )
N obs (rjssl )
N obs (r. ss. )

N obs ( p.ss. , r. ss. , tm )
X tm =
N obs ( p.ss. , r. ss. , t. )
Bc = N obs ( p.ss. , r. ss. , tm )

Similar to other interaction propensity scoring functions, it is computed from the logarithm of
ss

ss

ss

ss

observed cases ( N obs ( pi k , rj l , tm ) ) over expected cases ( N exp ( pi k , rj l , tm ) ). PRInter
applied three unbiased fractions X i , ssk , X j , ssl , X tm and the pseudocount will be divided by
480 as there are in total 480 combinations (20 amino acids, 3 amino acid secondary structure
states, 4 nucleotides, 2 nucleotides secondary structure states). As we discussed in PInter,
Interaction type correction term is applied to PRInter as we have discussed in PInter.

3.3.3 Develop protein-RNA threading and scoring scheme
3.3.3.1 Protein threading and scoring

RaptorX, the best template-based modeling method in Critical Assessment of Protein
Structure Prediction 9 (CASP9), is used for protein interface threading problem. RaptorX is
equipped an integer linear programming (ILP) scheme so that when searching and aligning to
template(s), RaptorX optimizes the objective function which involves sequence profile
similarity, statistical potential-based sequence similarity, secondary structure profile
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similarity, solvent accessibility, contact capacity, environment fitness, sequence identity,
alignment length and gaps simultaneously 77,78. Therefore, this tool is ideal for fold
recognition using low-homology template(s). Here, non-redundant protein structures in nrPR
database will be treated as the templates to thread the target protein sequence. Based on the
alignment provided by RaptorX, we calculated the interface threading score as following:

E pThread =

(E

q
pInter

norm
E pThread
= E pThread

)

q
q
+ E pDist
+ E pGap
− ( E tpInter + E tpDist )
penalty

∑ψ  dθ 
t

t
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The secondary structure of the target protein will be predicted by RaptorX internally using
PSIPRED method [88]. The probability of each residue being α-helix, β-sheet or loop, namely
q

t

pssk , will be incorporated into the function. The overscript (e.g., X or X ) indicates whether
the profile (X) is retrieved from template or query. To compare the protein interface threading
scores for proteins with different length, we normalize the final score (calculated from query
threading scores minus template threading scores) by “effective length”, in which greater
t

weight will be placed on the region that is closer to interface, we transform the distance ( dθ )
using a sigmoid function (ψ ):

ψ  dθ  =

1

t





1+ e

 t

− A  dθ − s 






t




Then effective length is the summation of ψ  dθ  for all the positions in template sequence.
Here constant c defines the minimum weight after transformation, A controls the overall
t

steepness of sigmoid curve and s affects descending rate for small dθ values. We use, s=8.0,
A= -0.8 for maximum performance. Considering the nature of RPI, we take into account two
nonspecific interaction schemes in protein threading scoring or protein-RNA interface
threading scoring (Fig. 3.3). First, salt bridge (electrostatic attraction) is considered as
sequence-independent interaction. If a query alignment position (q) fails to form salt bridge
interaction with RNA (as indicated by the template), we search the surrounding q ±3 positions
for Arg or Lys, and use the best score when calculating the contribution of this position to
q
E pInter
(Fig. 3.3 left). Second, base stacking interaction is considered as type-independent

interaction. In this exception, if a query alignment position (q) is unable to form a specific
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stacking interaction (tm) (as indicated by the template), we calculate the interaction propensity
using other t’m s which are classified in the same category of tm (Fig. 3.3 right). The gap
penalty coefficient α is -2 when there presents a gap in the query sequence.
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Fig. 3.3. Scheme of the nonspecific interactions in PRInter scoring. (A) salt
bridge (electrostatic attraction) is considered as sequence-independent interaction.
(B) base stacking interaction is considered as type-independent interaction.
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3.3.3.2 RNA threading and scoring

LocARNA utilizes dynamic programming (DP) for RNA alignment with dedicate
consideration of secondary structure of nucleotides [89, 90]. The secondary structure and the
base pair probability of the query RNA is predicted by CentroidFold [91], one of the most
robust RNA secondary structure prediction tools benchmarked by CompaRNA [92]. The base
pairing probabilities for each nucleotide in the query sequence are predicted using
CentroidFold, and will be used as inputs for LocARNA. Similar to that for protein threading,
we have RNA threading score as following:

E pThread =

(E

q
pInter

norm
E pThread
= E pThread

)

q
q
+ E pDist
+ E pGap
− ( E tpInter + E tpDist )
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Besides RInter and RDist, no nonspecific threading term (e.g., salt or base stacking terms) are
applied. Since it is infeasible to estimate the importance of RNA secondary structure a priori,
we perform greedy searches for the optimal values of “structweight” parameter at an interval
of 50, and “indel” and “indel-opening” at an interval of 0.5, and the RNA alignment that
obtains the best score will be retained. Other parameters are identical to those in protein
threading.

3.3.3.3 Protein-RNA interface threading and scoring

Based on the protein alignment provided by RaptorX and RNA alignment provided by
LocARNA, we are able to predict the query interface and align to the template interface. Here
we hypothesized that 1) the interaction type of each residue/nucleotide at interface can be
inferred from its homologous interface; 2) the missing residues, namely gaps, at interface

alignment are detrimental to the binding. The performance of protein-RNA interface
norm
threading is scored by E prThread
, as following:

(

)

q
q
t
E prThread =
E prInter
+ E prGap
− ( EInter
)
penalty

norm
= E prThread / N t p ⊗t r
E prThread

Where:
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Similar to the calculation for protein threading score, we applied the salt and stacking
corrections for nonspecific interaction schemes in interface threading. Here t p ⊗ t r denotes
the interface element in the template or the corresponding query interface, where a template
protein residue in the template ( t p ) interacts with a template nucleotide ( t r ). Therefore,

N t p ⊗t r denotes the number of direct contacts in the template, which will be used as a
norm
. As the secondary structure states of amino
normalization factor when computing E prThread

acids and nucleotides are all from predictions, the interaction propensity are computed as the
sum of dot product of the residues with all secondary structure states (for amino acids: H, E,
C and for nucleotides: WC, nP).
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3.3.4 Develop Random Forest classification models
3.3.4.1 Collect interface profiles to train classification models

Unlike protein-protein interaction, the publicly available resources for protein-RNA
interaction are greatly limited. Furthermore, it is generally more dangerous to scramble the
positive dataset to derive the non-interacting negative controls for protein-RNA interaction, as
RNA only contains four types of residue (variables), where the probability of chance binding
is significantly higher than that of protein when data shuffling is performed. Here we train the
machine learning classifier with three resources: NPInter [93], RBPDB [94] and NNBP [95].
Briefly, we have collected 14,623 protein-RNA positive pairs from NPInter, and 3,649
negative pairs from RBPDB using PSSM motif scanning searching for RNAs in NPInter that
are less likely to bind (<5%). In addition, for each protein in NNBP that is confirmed not to
interact with any nucleosides, we randomly selected 50 RNAs from NPInter, and formed
12,500 negative pairs.

Two independent datasets were collected for external validation. First dataset contains 11,709
protein-mRNA interaction pairs from Saccharomyces genome database (SGD) [96]. The
4,706 negative pairs generated by random shuffling were obtained from RPIseq validation set,
which was retrieved from [54]. This independent dataset was used in the previous method
benchmarks, such as RPISeq [54] and Pancaldi and Bähler et al. [97]. The second dataset was
compiled from 42 most recent discoveries of miRNA-protein interactions (Table 3.2), and we
will compare the performances of interface threading method with those by RPISeq using
these two validation sets.
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Table 3.2. External validation dataset (II). In the binding column, 0-no binding detected, 1binding is observed. CoIP: coimmunoprecipitation. MS: mass spectrum. WB: western blot.
RIP: RNA immunoprecipitation.

Gene
HNRNPA1

Uniprot ID
P09651

miRNA
pre-mir-18a

Experiment
CoIP

PubMed_ID
17558416

Bind?
1

HNRNPA1

P09651

pre-let-7a-1

CoIP

20639884

1

HNRNPA1

P09651

pre-mir-101-1

18995836

1

HNRNPL

P14866

pre-let-7a-1

18995836

1

PCBP2

Q15366

mir-181b-5p

RNA chromatography
MS; WB
RNA chromatography
MS; WB
RIP

20211135

0

PCBP2

Q15366

mir-330-5p

UV crosslinking; RIP

20211135

0

PCBP2

Q15366

mir-328

20211135

1

PTBP1

P26599

pre-mir-101-1

18995836

1

HNRNPK

P61978

mir-328

UV crosslinking; RIP;
EMSA
RNA chromatography
MS; WB
Preliminary data

20211135

1

ELAVL1

Q15717

mir-29b-3p(mut)

CoIP

23901138

0

ELAVL1

Q15717

mir-29b-3p

CoIP

23901138

1

KHSRP

Q92945

pre-mir-21

19458619

1

KHSRP

Q92945

pre-mir-1-2

CoIP; NMR; UV
crosslinking
crosslinking; CoIP

23221640

1

KHSRP

Q92945

pre-let-7a-1

Q14103

pre-mir-155

20639884;
19458619
19423639

1

HNRNPD

CoIP; NMR; UV
crosslinking
Preliminary data

KHSRP

Q92945

pre-mir-23b

CoIP

19423639

0

ZFP36

P26651

pre-mir-155

CoIP

19423639

0

KHSRP

Q92945

pre-mir-155

CoIP

19423639

1

LIN28b

Q6ZN17

pre-let-7f1

Crystalized

22078496

1

LIN28b

Q6ZN17

pre-let-7d

Crystalized

22078496

1

LIN28b

Q6ZN17

pre-let-7g

Crystalized

22078496

1

TLR7

Q9NYK1

let-7b-5p

22610069

1

TLR7

Q9NYK1

let-7a-5p

22610069

1

TLR7

Q9NYK1

let-7c

22610069

1

TLR7

Q9NYK1

let-7g-5p

22610069

1

TLR7

Q9NYK1

mir-599

22610069

1

TLR7

Q9NYK1

mir-124-3p

22610069

0

TLR8

Q9NR97

mir-21-5p

Indirect assay with
exogenous miRNA
Indirect assay with
exogenous miRNA
Indirect assay with
exogenous miRNA
Indirect assay with
exogenous miRNA
Indirect assay with
exogenous miRNA
Indirect assay with
exogenous miRNA
CoIP; Colocalization

22753494

1

TLR8

Q9NR97

mir-29a-3p

CoIP; Colocalization

22753494

1

TLR8

Q9NR97

mir-16-5p

CoIP

22753494

0

TLR8

Q9NR97

mir-147a

Indirect assay with
exogenous miRNA

22753494

1
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0

QKI6

Q9QYS9

mir-20a-3p

CoIP

22751500

1

QKI6

Q9QYS9

pre-mir-20a

CoIP

22751500

0

QKI6

Q9QYS9

mir-18a-5p

CoIP

22751500

0

QKI6

Q9QYS9

mir-20a-5p

CoIP

22751500

0

QKI6

Q9QYS9

pre-mir-7-1

CoIP

23319046

1

SND1

Q7KZF4

pre-miR-92a-2

RIP

23770094

1

SND1

Q7KZF4

mir-17-5p

RIP

23770094

1

SND1

Q7KZF4

mir-18a-5p

RIP

23770094

1

SND1

Q7KZF4

mir-19a-5p

RIP

23770094

1

SND1

Q7KZF4

mir-20a-5p

RIP

23770094

1

SND1

Q7KZF4

mir-92a-5p

RIP

23770094

1
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3.3.4.2 RPIT-RF model

The ultimate goal is to determine whether the query protein interacts with the query RNA
based on the interface score profiles computed previously. Since only a few protein-RNA
pairs interact in vivo, the main challenge is to discriminate the true interactions from the false
ones. Here, we extract a vector of interface profile, X Interface , and feed this profile to various

classifiers, which compute the probability of interacting:

p = ζ ( X Interface )
X Interface = { pThread , rThread , prThread

}

Where:
q
q
tP, qP, e P, iP, rapscore , rap pval , rapNEFF , E pInter
, N pInter
, E tpInter , N tpInter , 
pThread =  q

t
q
q
q
q
norm
 E pDist , E pDist , E pGap penalty , N pGap penalty , E pGapaffinity , N pGapaffinity , E pThread , E pThread 
q
q
t
t
tR, qR, e R, iR, locscore , locssweight , locgap , ErInter
, N rInter
, ErInter
, N rInter
, 
rThread =  q
t
q
q
q
q
norm 
 ErDist , ErDist , ErGap penalty , N rGap penalty , ErGapaffinity , N rGapaffinity , ErThread , ErThread 

{

q
t
t
q
q
q
norm
q
prThread = E prInter
, N prInt
er , E prInter , N prInter , E prGap penalty , N prGaphalf , N prGap full , E prThread , E prThread

tP and tR are the length of template protein or RNA. qP and qR are the length of query
protein (or RNA). ε P and ε R are the effective length of the protein (or RNA), which are
employed to normalize the interaction score. iP and iR are the sequence identity between the
template and query protein (or RNA). rapscore , rap pval , rapNEFF are the threading score, pvalue, and NEFF value calculated by RaptorX. locscore , locssweight , locgap are the best threading
score, secondary structure weight, and gap penalty score from LocARNA. Feature importance
norm
norm
, ErThread , ErThread
showed that features other than rapscore , rap pval , rapNEFF , E pThread , E pThread
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}

norm
E prThread , E prThread
are less informative (data not shown). Thus, the final classifier will only

have the above nine features as the attributes.

3.3.4.3 Metrics for model quality assessment

We evaluated the predictive ability of classifiers by sensitivity, specificity, positive predictive
value (PPV), negative predictive value (NPV), F1 measurement, Matthews correlation
coefficient (MCC), overall accuracy, and ROC AUC. These metrics are calculated as
following, in which TP = true positive, FP = false positive, TN = true negative, FN = false
negative:
Sensitivity = TP / (TP + FN)
Specificity = TN / (TN + FP)
PPV = TP / (TP + FP)
NPV = TN / (TN + FN)
F1 = 2 × sensitivity × PPV / ( sensitivity + PPV )
MCC = (TP × TN − FP × FN ) / (TP + FP ) (TP + FN )(TN + FP ) (TN + FN )
Accuracy = (TP + TN) / (TP + TN + FP + FN)

The F-measurement is a harmonic mean of precision and recall. F-measurement, e.g., F1
value, ranges from 0 to 1, and value close to 1 indicates perfect classifier. MCC value, often
known as φ-coefficient, is essentially a correlation coefficient between the observed and
predicted classification. Its value ranges from -1 to 1 where 1 indicates prefect classification,
0 means random, and -1 indicates a total disagreement. The ROC AUC evaluates the
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performance of binary classifier with varied discrimination threshold. Its value ranges from 0
to 1 and AUC = 1 indicates a perfect classifier and AUC = 0.5 indicates random classifier.

3.3 Results: Interface threading approach to predict RNA-protein binding
3.3.1 nrPR database
The quality and diversity of nrPR template database may directly affect the accuracy and
applicability of interface threading implementation. nrPR database consists of 5,471 nonredundant protein-RNA pairs, including 69% crystal structures, 2% NMR structures and 29%
electron microscopy structures (Fig. 3.4A). A majority of crystal structures (76.5%) acquire
acceptable resolutions (resolution < 3.5Å), with most around 3.0Å (Fig. 3.4B). The median
resolution is 3.1Å. Although the quality of 3D structures are not ideal compared with other
collections, we think it is acceptable if considering the tradeoff between database coverage
and quality. Indeed, the statistical scoring functions in this implementation can tolerate the
trivial errors in structural models, because they only consider a binary response (interface or
non-interface residue) for interaction propensity calculation and the distance range (d<cutoff)
for distance propensity calculation.

Analysis of the lengths of interacting protein and RNA pairs has shown three major clusters in
nrPR (Fig. 3.4C). First cluster involves small to large size protein (75-500 aa) interacting
with small RNA (<500 nt). Second and third clusters include medium size protein (100-250
aa) interacting with medium (1000-2000 nt) or large size RNA (2500-3500 nt), respectively.
Regardless the wide variation in macromolecular lengths, the number of interfacial amino
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acids and nucleotides show a clear correlation (R2 = 0.84) (Fig. 3.4D), in which amino acid
on average interacts with 0.68 nucleotide at interface region (amino acid to nucleotide ratio
(ANR) = 1.48 ± 0.99). This ANR is in contrast to that of protein-DNA interface, whose ANR
is about 2 (24 ± 6 aa vs. 12 ± 3 nt [98] and 52 ± 25 aa vs. 23 ± 9 nt [51]). Our data is also
distinct from any previous statistical analyses using small dataset (< 200 samples), which
usually reported ANR > 2.5 [51]. We observed a considerable variation of ANR values
(ranging from 0.33 to 12.5), which indicates that diverse protein/RNA families have been
collected. Interesting, we find length of protein (or RNA) non-informative to predict of
number of interface residue, as there are no correlations between length of protein (RNA) and
number of interfacial residues (nucleotides) (Fig. 3.4E-F). PCA using triad conjoint
descriptors demonstrates that the nrPR database is absent of significant clusters (Fig. 3.5A),
in which first two principle components (PCs) only accounts for <10% variance amongst all
protein sequences. Pairwise-sequence/secondary structure/interaction similarity distribution
could be fitted to a normal distribution, 𝑝~𝒩(𝑚𝑚𝑚𝑚 = 42.15%, 𝜎 2 = 66.77) with low

RMSE = 3.02 (Fig. 3.5B). All these data suggest that nrPR database represents an unbiased

collection of RNA-protein interfaces, and the diversity in sequence/structure/interaction
should be sufficient to achieve statistical power for scoring functions implementations.
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Fig. 3.4. Statistics of nrPR database. (A) composition of 3D structures. (B) Distribution of
resolution for all cystal structures. (C) Distribution of the length of protein vs. length of RNA
for protein-RNA interacting pairs in nrPR. (D) Distribution of number of interfacial amino
acid and interfacial nucleotides for the interfaces in nrPR. (E) Distribution of the number of
interfaical residues vs. length of protein. (F) Distribution of the number of interfaical
nucleotides vs. length of RNA.
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Fig. 3.5. Sequence and structural diversity of nrPR database. (A) Scatter plot of
first two principle components of nrPR database using conjoint triad descriptors. (B)
Distribution of pairwise-RNA-protein pair similarity in nrPR database. The blue line
indicates the normal distribution of the pairwise similarity.
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3.3.2 Statistical scoring functions
Table 3.3 and Table 3.4 summarized some basic statistics for amino acid or nucleotide at
protein-RNA interface. We find that amino acids in coil state are statistically more favorable
at protein-RNA interface than other secondary structure states (p < 0.01) (Fig. 3.6). This
agrees with previous finding that protein-RNA interfaces are packed less tightly than those of
protein-DNA and protein-protein interface.

Fig. 3.7A shows the heat map for PInter scoring function. Consistent to the amino acid
preference [52] and secondary structure preference we have observed, general vdW
interaction potentials exhibit significant variances (p = 5.15e-15 for amino acid factor and p =
1e-11 for secondary structure factor, two-way ANOVA). Coiled amino acid and positively
charged residues are more favorable to protein-RNA interface. Other type-specific potentials,
such as arom, arom_l, cpi, hy and salt, hbp_1, hbp_2 obtain expected preferences to specific
amino acids. T, S, R, K, H, Q, N are more likely to be recognized by RNA nucleotides by
forming more than two H-bonds with their sidechain atoms (p < 1e-5). Intriguingly, negatively
charged residue (D, E) as well as these seven residues (T, S, R, K, H, Q, N) are more likely to
recognize specific nucleotide judged by high hbr_2 propensities (p < 1e-5). Later we will show
in Fig. 3.8 that even if D and E are generally disfavored on protein-RNA interface, they
preferably form H-bonds with specific nucleotides if they happen to be on the interface.

In contrast, the potential of RNA nucleotides to interaction with protein depend more on
secondary structure states (Fig. 3.7B). Arom, arom_l, cpi, hbr_2, and hy interactions have
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greater propensity to occur on unpaired/noncanonical base paired nucleotides than WatsonCrick/G-U wobble base paired ones. In terms of sequence-specific interaction, guanine and
cytosine are most likely to be “recognized” by forming more than two H-bonds with protein
residues. However, nucleotide type and secondary structure states cannot determine the
interaction propensity to form backbone recognition (pbb_p, ss = 0.61, pbb_p, na = 0.94, pbb_r, ss =
0.08, pbb_r, na = 0.42), protein sequence recognition (hbp_1, hbp_2), salt and vdW interactions
according to two-way ANOVA test.

Fig. 3.8 summarizes the interaction propensities between interfacial protein residues and
RNA nucleotides. The nonspecific interactions (arom, arom_l, bb_p, bb_r, cpi, hy, salt and
vdw) show similar patterns with those of PInter. With respect to hbr_2 and hbp_2
propensities, some favorable amino acid-nucleotide specific interactions have been detected
(superscripts indicate the secondary structure state):

1. AnP is favorably recognized by VE / T / S / Q / NE / KE / IE / HE / DE / CC / AE, whereas
AnP : T, AnP : S, AnP : NE, AnP : KE shows more specific bilateral recognition judged
by both high hbp_2 and hbr_2 propensities, and other interactions are unilateral
recognition only to nucleotide. Compared to the bilateral recognitions involved with
other nucleotidesnP, there is a statistically significant weaker propensities for AnP : R
(p = 3.5e-5). Fig. 3.9A-C shows some typical interactions found for nucleotidenP : R.
2. CnP is preferably recognized by T / S / R / MC / K, in which CnP : T, CnP : S, CnP : R
and CnP : S are bilateral recognitions, whereas CnP : MC is unilateral to nucleotide.
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Compared to the bilateral recognitions involved with other nucleotidesnP, there is a
statistically significant weaker propensities for CnP : Q (p = 0.0007).
3. GnP is preferably recognized by T / S / R / Q / NH / NC / MC / K / E / D. All except CnP :
MC recognize both amino acid and nucleotide types bilaterally. GnP : D and GnP : E
interactions are uniquely enriched for GnP (p = 0.015 for GnP : D and p = 0.0006 for
GnP : E). Fig. 3.9D-E illustrates typical sequence-specific interactions of GnP : D and
GnP : E.
4. UnP is preferably recognized by T / S / R / Q / N / MC / K / E / D. All except CnP : MC
recognize both amino acid and nucleotide types bilaterally. UnP : N, in particular, is
enriched compared with other nucleotide-Gln sequence-specific interactions (p =
0.028). Fig. 3.9F demonstrates a representative interaction pattern of UnP : N.
5. Surprisingly, GWC is the only paired nucleotideWC that have significantly greater
propensity to be recognized by T, S, R, Q, N, K (p < 10-5). Examples of GWCrecognition interaction are showed in Fig. 3.9G-H.

Amino acids demonstrate distinctive propensities to be on or close to protein-RNA interface
(Fig. 3.10). We can classify 20 amino acids into several groups based on their respective
distance propensity profile. (1) Non-aromatic, hydrophobic residues (Ala, Ile, Leu, Val),
especially in helix or sheet forms, are strongly unfavorable to protein-RNA interface until 5Å.
(2) Negatively charged residues (Asp and Glu) are unfavorable in any secondary structure
state, even at 10Å. (3) Sulfur-containing residues (Cys and Met) slightly prefer the interface
regions when they are in coil state, but disfavor when in helix or sheet state. (4) Hydrophobic
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residues with carbon-only ring (Phe, Pro) have neutral preference to the interface when in coil
state and slightly unfavorable in other states. (5) Gly has neutral preference at all states. (6)
Neutral hydrophilic residues (Asn, Gln, Ser, Thr) in coil form slightly favor the interface, but
neutral when in other forms. (7) Aromatic residues whose sidechains can be H-bond
donor/acceptor (Tyr, Trp) strongly favor the interface when in coil state, but neutral in other
states. (8) Positively-charged residues (His, Lys and Arg) significantly favor the protein-RNA
interface in any states. In comparison, the distance potential for RNA nucleotides fail to show
any significant difference between A, U, G, C and the potentials are always neutral at any
distance (Fig. 3.11), indicating that the distance propensity for RNA nucleotides might be
non-informative for RPI prediction.
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Table 3.3. Statistics of protein amino acids in nrPR database. Secondary structure states
were considered: H=helix, E=sheet, C=coil. The vdw interaction statistics for each residue
type were not shown as it equals to the total number of interfacial residue.
AA-ss

Interface / total

% Interface

Mean dist.

arom

arom_l

hy

cpi

hbr_2

hbr_1

hbp_2

hbp_1

bb_p

bb_r

salt

A
A-H
A-E
A-C

9989 / 73833
2873 / 31334
812 / 9203
6304 / 33296

13.53%
9.17%
8.82%
18.93%

6.04 ± 5.48
6.42 ± 5.49
5.97 ± 5.11
5.72 ± 5.55

0
0
0

0
0
0

117
26
343

0
0
0

0
5
7

42
30
214

0
0
0

0
0
0

326
87
1151

284
62
986

0
0
0

C
C-H
C-E
C-C

779 / 6927
144 / 1892
117 / 1682
518 / 3353

11.25%
7.61%
6.96%
15.45%

5.99 ± 5.43
7.30 ± 5.41
6.19 ± 5.23
5.17 ± 5.40

0
0
0

0
0
0

0
0
0

0
0
0

0
0
4

13
3
32

1
0
11

15
14
91

11
6
44

13
17
110

0
0
0

D
D-H
D-E
D-C

4353 / 38901
890 / 10020
615 / 4918
2848 / 23963

11.19%
8.88%
12.51%
11.88%

7.06 ± 5.69
7.59 ± 5.67
6.68 ± 5.39
6.92 ± 5.75

0
0
0

10
0
45

0
0
0

0
0
0

7
10
27

40
81
233

23
9
59

203
177
491

36
20
271

210
115
558

0
0
0

E
E-H
E-E
E-C

5454 / 58839
1670 / 23926
889 / 8339
2895 / 26574

9.27%
6.98%
10.66%
10.89%

7.39 ± 5.65
7.78 ± 5.63
6.94 ± 5.41
7.21 ± 5.73

0
0
0

13
17
23

0
0
0

0
0
0

78
31
21

116
80
160

84
40
48

274
214
420

91
88
288

241
225
561

0
0
0

F
F-H
F-E
F-C

4421 / 28797
716 / 8617
1147 / 7380
2558 / 12800

15.35%
8.31%
15.54%
19.98%

6.17 ± 5.47
6.92 ± 5.48
5.90 ± 5.30
5.84 ± 5.52

102
155
210

0
0
0

0
0
0

0
0
0

0
8
8

5
9
24

0
0
0

0
0
0

27
91
165

22
75
133

0
0
0

G
G-H
G-E
G-C

13582 / 63588
1438 / 7849
1006 / 6958
11138 / 48781

21.36%
18.32%
14.46%
22.83%

5.63 ± 5.73
5.88 ± 5.82
6.06 ± 5.50
5.53 ± 5.74

0
0
0

0
0
0

0
0
0

0
0
0

0
2
9

55
8
465

0
0
0

0
0
0

281
139
2554

228
129
2147

0
0
0

H
H-H
H-E
H-C

6454 / 18531
1427 / 4884
1125 / 3670
3902 / 9977

34.83%
29.22%
30.65%
39.11%

4.59 ± 5.60
5.38 ± 5.89
4.82 ± 5.46
4.12 ± 5.45

82
45
240

0
0
0

0
0
0

0
0
0

0
4
2

43
23
192

5
4
27

357
225
807

49
35
337

356
220
934

0
0
0

I
I-H
I-E
I-C

5946 / 51161
1415 / 15768
1560 / 16466
2971 / 18927

11.62%
8.97%
9.47%
15.70%

6.15 ± 5.40
6.47 ± 5.54
6.14 ± 5.23
5.91 ± 5.41

0
0
0

0
0
0

273
215
456

0
0
0

0
12
3

33
37
58

0
0
0

0
0
0

54
145
265

21
111
213

0
0
0

K
K-H
K-E
K-C

25285 / 73269
5910 / 22622
3728 / 10347
15647 / 40300

34.51%
26.13%
36.03%
38.83%

4.86 ± 5.73
5.61 ± 5.89
4.72 ± 5.45
4.50 ± 5.68

0
0
0

0
0
0

0
0
0

29
17
67

107
43
111

558
296
1128

672
340
1665

2986
1872
7112

367
223
1484

3188
1962
8068

2859
1802
6966

L
L-H
L-E
L-C

7856 / 73356
1963 / 30793
1295 / 14028
4598 / 28535

10.71%
6.37%
9.23%
16.11%

6.25 ± 5.36
6.68 ± 5.37
6.26 ± 5.10
5.81 ± 5.43

0
0
0

0
0
0

180
203
615

0
0
0

0
4
5

21
12
62

0
0
0

0
0
0

146
83
401

125
67
336

0
0
0

M
M-H
M-E
M-C

3110 / 17551
737 / 6807
380 / 2874
1993 / 7870

17.72%
10.83%
13.22%
25.32%

6.10 ± 5.64
6.82 ± 5.69
5.90 ± 5.17
5.57 ± 5.70

0
0
0

0
0
0

136
53
478

0
0
0

0
0
24

35
2
172

0
0
0

94
22
204

76
35
436

128
54
480

0
0
0

N
N-H
N-E
N-C

7356 / 30214
1860 / 8224
643 / 3307
4853 / 18683

24.35%
22.62%
19.44%
25.98%

5.88 ± 5.89
6.06 ± 5.83
6.48 ± 5.94
5.70 ± 5.90

0
0
0

28
9
64

0
0
0

0
0
0

53
8
33

149
59
344

129
27
191

616
225
1404

52
34
482

609
207
1586

0
0
0

P
P-H
P-E
P-C

6565 / 36190
656 / 5018
524 / 3728
5385 / 27444

18.14%
13.07%
14.06%
19.62%

6.28 ± 5.82
7.14 ± 5.86
6.22 ± 5.30
6.14 ± 5.87

0
0
0

0
0
0

59
144
663

0
0
0

0
0
3

3
5
71

0
0
0

0
0
0

30
82
417

27
77
352

0
0
0

Q
Q-H
Q-E
Q-C

6814 / 29162
1897 / 11007
1054 / 4282
3863 / 13873

23.37%
17.23%
24.61%
27.85%

5.64 ± 5.70
6.32 ± 5.71
5.52 ± 5.52
5.17 ± 5.70

0
0
0

15
16
91

0
0
0

0
0
0

45
41
36

253
108
277

135
87
175

693
302
1112

84
67
454

662
335
1314

0
0
0

R
R-H

30332 / 72257
8508 / 23446

41.98%
36.29%

4.16 ± 5.58
4.74 ± 5.81

0

241

0

267

119

334

1554

3508

357

4345

4741

95

R-E
R-C

4678 / 11723
17146 / 37088

39.90%
46.23%

4.09 ± 5.29
3.83 ± 5.50

0
0

95
821

0
0

91
613

53
225

206
1013

743
2842

1713
6502

231
1615

2164
8271

2293
8625

S
S-H
S-E
S-C

9482 / 40149
1948 / 10576
1053 / 5872
6481 / 23701

23.62%
18.42%
17.93%
27.34%

5.94 ± 6.00
6.71 ± 6.08
6.36 ± 5.73
5.51 ± 5.99

0
0
0

0
0
0

0
0
0

0
0
0

21
19
142

217
113
676

136
67
443

826
424
2436

229
50
1032

837
403
2633

0
0
0

T
T-H
T-E
T-C

9265 / 41581
1356 / 8832
1993 / 10204
5916 / 22545

22.28%
15.35%
19.53%
26.24%

5.65 ± 5.69
6.65 ± 5.88
5.62 ± 5.35
5.30 ± 5.73

0
0
0

0
0
0

0
0
0

0
0
0

6
61
89

115
114
478

64
114
349

558
573
2019

146
240
802

566
691
2268

0
0
0

V
V-H
V-E
V-C

7860 / 70838
1179 / 16774
2053 / 25822
4628 / 28242

11.10%
7.03%
7.95%
16.39%

5.99 ± 5.22
6.42 ± 5.34
5.99 ± 4.93
5.74 ± 5.40

0
0
0

0
0
0

133
109
492

0
0
0

0
13
2

12
26
37

0
0
0

0
0
0

69
168
474

57
131
440

0
0
0

W
W-H
W-E
W-C

1602 / 6505
362 / 2282
277 / 1417
963 / 2806

24.63%
15.86%
19.55%
34.32%

5.54 ± 5.61
6.41 ± 5.74
5.88 ± 5.49
4.71 ± 5.45

54
26
141

0
0
0

0
0
0

0
0
0

0
0
0

5
13
15

3
5
2

46
57
134

12
11
136

51
62
231

0
0
0

Y
Y-H
Y-E
Y-C

6220 / 24749
1305 / 7706
1590 / 6648
3325 / 10395

25.13%
16.93%
23.92%
31.99%

5.44 ± 5.70
6.55 ± 5.87
5.45 ± 5.49
4.67 ± 5.58

134
159
242

0
0
0

0
0
0

0
0
0

2
4
3

50
105
110

36
69
86

444
557
890

35
57
175

470
599
988

0
0
0
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Table 3.4. Statistics of RNA nucleotides in nrPR database. Secondary structure states were
considered: WC=Watson-Crick or GU wobble base pair, nP=other noncanonical base pair or
no base pair. The vdw interaction statistics for each residue type were not shown as it equals
to the total number of interfacial residue.
NA-ss

Interface / total

% Interface

Mean dist.

arom

arom_l

hy

cpi

hbr_2

hbr_1

hbp_2

hbp_1

bb_p

bb_r

salt

A
A-WC
A-nP

38140 / 2070177
8437 / 442783
29703 / 1627394

1.84%
1.91%
1.83%

9.27 ±6.54
9.05 ±6.54
9.32 ±6.54

14
694

33
485

131
1603

26
414

7
183

320
1362

536
1755

2270
7185

933
2828

3157
9452

1752
5911

U
U-WC
U-nP

27533 / 1570531
11438 / 678220
16095 / 892311

1.75%
1.69%
1.80%

9.16 ±6.50
9.14 ±6.51
9.18 ±6.50

11
308

51
262

78
936

46
181

12
169

479
1437

751
1020

3187
4655

1356
1840

4407
5480

2663
3435

G
G-WC
G-nP

48756 / 2810137
30060 / 1744408
18696 / 1065729

1.74%
1.72%
1.75%

9.11 ±6.47
9.07 ±6.45
9.19 ±6.50
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Fig. 3.6. Percentage of interfacial protein residue with different secondary structure
states. The boxplot was generated by ggplot2 library in R statistical package.
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Fig. 3.7. Heat map of interaction potentials for protein or RNA residues. (A) amino acids in
different secondary structure states. (B) nucleotides in different secondary structure states.
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Fig. 3.8. Heat map of interaction potentials between protein-RNA residues.
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Fig. 3.9. Representative bilateral sequence-recognition interaction on proteinRNA interface. Intermolecular H-bonds are displayed as yellow dashes.
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Fig. 3.10. Distance potentials for protein residues. The amino acids are sorted in a rough
ascending order according to overall preferences to protein-RNA interface (most disfavored
to most favored).

102

Fig. 3.11. Distance potentials for RNA nucleotides. Unlike those for amino acids,
nucleotides are not sorted due to insignificant difference among groups.
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3.3.3 Performance evaluation of RPIT
The conventional way of evaluating the robustness of a classifier is through leave-one-out or
leave-group-out cross validation. However, due to the sparseness of protein profile in the
training set (protein profile is heavily clustered due to the lack of mutagenesis data), these
cross validation strategies could be unreasonably biased. Actually, we found that the
classification metrics (e.g., sensitivity, specificity, PPV, NPV, ROC AUC, etc.) were way
above 95% if 10-fold or 20-fold stratified cross validation was performed, even using
different classifiers (data not shown). Instead, we assessed the robustness of model by leaveprotein-out cross-validation (LPOCV). As a result, the random forest classifier (RPIT-RF) and
quadratic discriminant analysis classifier (RPIT-QDA) outperformed other methods in terms
of their outstanding ROC AUCs (AUCRPIT-RF = 0.93, AUCRPIT-QDA = 0.93) (Table 3.5 and Fig.
3.12A). In particular, LPOCV of RPIT-RF resulted in outstanding predictive metrics
(sensitivity = 0.89, specificity = 0.84, MCC = 0.69). Removal of any attributes from RPIT-RF
(either protein, RNA or interface term) compromised the LPOCV performance (Fig. 3.12B),
indicating that the interface threading score carry relevant information to make reasonable
RPI predictions. Furthermore, random forest classifier using only protein and RNA sequence
identity information predict significantly worse than the RPIT-RF (Fig. 3.12B), indicating
that the naïve assumption that interfaces with similar protein/RNA sequences have similar
binding response is not applicable here. Y-randomization abolished the predictive ability,
which implied that the model was not generated by chance (Fig. 3.12B). Similar trends could
also be observed for RPIT-QDA in LPOCV (Fig. 3.12C).
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Then we validated our RPIT-RF and RPIT-QDA classifiers with an independent external test
set, comprising of 11709 known yeast mRNA-protein interaction pairs and 4709 negative
pairs generated with data shuffling. Similar to LPOCV results, PRIT-RF achieved the best
performance with respect to ROC AUC (AUC = 0.71) (Table 3.5). In comparison, other
method, except AdaBoost (another ensemble classifier), received ROC AUC close to 0.5 (Fig.
3.13A and Table 3.5), which indicates the low predictive capabilities for QDA, LDA, KNN
and Naïve Bayes. Notably, we observed that most classifiers, including RPIT-RF, obtained
much better performances in sensitivity than specificity. This is probably due to the fact that
the negative set we used for external validation is originated from data shuffling, and the
probability of have false negative pair can be significant. In addition, removal of any
attributes (protein/RNA/interface) or using only sequence identity information as features
could dramatically compromise ROC AUCs (AUCΔProtein = 0.45, AUCΔRNA = 0.51,
AUCΔInterface = 0.59), as shown in Fig. 3.13B. Consistent to the observation from LPOCV,
random forest classifier fed with protein and RNA sequence identity information predicted
RPI no better than Y-randomization in this validation (AUCSeqIden = 0.51) (Fig. 3.13B).

To further validate our model in a more unbiased manner, we evaluated RPIT-RF on 42 most
recent discoveries of miRNA-protein interactions (Table 3.2). Here the ROC AUC metric
may not achieve enough statistical power due to the small size of this dataset. We herein only
reported the overall accuracy. The predictive accuracy of RPIT-RF is 71.5%, which is
superior to that of RPISeq-RF (accuracy = 56.1%) and RPISeq-SVM (accuracy = 63.4%).
Although more aggressive validation is indeed needed, this validation set showed a proof-of105

principle that RPIT-RF can be used for prioritizing novel miRNA-protein interaction by
virtual screening.
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Training Set

Sensitivity
Specificity
PPV
NPV
F1
MCC
Accuracy
ROC AUC

RF
0.89
0.84
0.72
0.94
0.79
0.69
0.86
0.93

QDA
0.89
0.67
0.56
0.93
0.69
0.52
0.74
0.86

AdaBoost
0.77
0.86
0.72
0.89
0.74
0.62
0.83
0.89

LDA
0.68
0.86
0.70
0.85
0.69
0.55
0.81
0.85

kNN
0.68
0.86
0.69
0.85
0.68
0.54
0.80
0.83

NaïveBayes
0.91
0.64
0.54
0.94
0.67
0.51
0.72
0.83

Test Set

Table 3.5 Performance of different classifiers in protein-RNA interface threading. The
training set was validated by leave-protein-out cross-validation, and we validated classifiers
based on an external test set.

Sensitivity
Specificity
PPV
NPV
F1
MCC
Accuracy
ROC AUC

0.79
0.49
0.79
0.48
0.79
0.28
0.70
0.71

0.82
0.18
0.71
0.29
0.76
0.00
0.63
0.48

0.75
0.35
0.74
0.36
0.75
0.10
0.64
0.61

0.33
0.61
0.68
0.27
0.45
-0.05
0.41
0.47

0.41
0.53
0.68
0.27
0.51
-0.05
0.44
0.46

0.84
0.14
0.71
0.26
0.77
-0.03
0.64
0.49
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Fig. 3.12. ROCs in LPOCV. (A) Comparison of different classifiers. The grey dashed
lines indicates the random prediction. (B) Comparison of random forest classifiers
with/without critical interface threading attributes (protein/RNA/interface), using only
sequence identities, and Y-randomization. (C) Comparison of QDA classifiers
with/without critical interface threading attributes (protein/RNA/interface), using only
sequence identities, and from Y-randomization.
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Fig. 3.13. ROCs in external validation. (A) Comparison of different classifiers. The grey
dashed lines indicates the random prediction. (B) Comparison of random forest classifiers
with/without critical interface threading attributes (protein/RNA/interface), using only
sequence identities, and from Y-randomization.
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3.5 Discussion
Computational modeling of RPI primarily concentrated on the identification of interface
residue (or nucleotide) that is likely to bind nucleotide (or protein residue) (see [99] for
complete review). In contrast, the “interaction pair prediction problem” is largely overlooked.
Despite the recent advancement of experimental high-throughput screening technology (e.g.,
PAR-CLIP [100], RIP-Chip [101], RNAcompete [102], HITS-CLIP [103]) which shed new
light on RPI network, computational method that predict RPI network is still in the “budding
stage”. As we have discussed in the introduction, either sequence-based or structure-based
method has its respective advantages and limitations. Taking the challenge to balance the
model robustness (drawback of structure-based method) and noise tolerance capacity
(drawback of sequence-based method), in this chapter we implemented an interface threading
pipeline, called RPIT, for in silico prediction of RNA-protein interactions (RPI) using a
reference RNA-protein interface as template and in-house developed statistical scoring
functions. Compared with template-free, sequence-based method, interface threading restrains
the alignment and scoring to only those residues which are most likely to be involved in the
RPI. Compared with structure-based method, RPIT is independent of the 3D structure
information and is more robust when the sequence homology is so low that hampers the
prediction of tertiary structure. On the whole, our results showed encouraging accuracy (70%80%), which is comparable to that of RPISeq (78% for RPISeq-RF and 65% for RPISeq-SVM)
and Pancaldi and Bähler et al.’s, accuracy = 70%. Furthermore, RPIT-RF is more robust due
to a significantly reduction of features (9-feature vector) compared to RPISeq which used 599
conjoint triad features, and Pancaldi and Bähler et al.’s which utilized 100 different features
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(including mRNA half-life, predicted secondary structure, GO annotation, amino acid
composition, codon bias, etc.) which is often unavailable in many cases. Third, two
independent validations have suggested that RPIT-RF is valuable for predicting and analyzing
regulatory RPI networks.
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Chapter 4: Summary and future directions
4.1 Summary of three-step virtual screening and its application
In Chapter 2.3, we have benchmarked and compared the possibility of translating 5 docking
software and 11 scoring functions to RNA-ligand docking and virtual screening using the
largest-ever RNA-ligand complex structure dataset and RNA-ligand binding affinity dataset.
Comprehensive statistical analyses have been applied to assess the performance in various
aspects: pose reproduction, pose ranking, score-RMSD correlation, and virtual screening
enrichment. From this benchmark, we have successfully identified the best combinations for
RNA virtual screening: rDock:rDock_solv – ASP rescoring – iMDLScore2 second rescoring
for flat, open and flexible binding sites of RNAs, while GOLD:GOLD Fitness – ASP
rescoring – rDock_solv second rescoring could be more appropriate for solvent inaccessible
and rigid RNA targets, as demonstrated by Fig. 2.9.

GA:UU tandem mismatch is a conserved RNA motif frequently found in bacteria rRNA.
Using the three-step docking/scoring scheme for structure-based drug design that we have
developed in Chapter 2.3, we have successfully identified compound 423 that demonstrates
specific binding to RNAs at GA:UU internal loop. Both 1D and 2D NMR spectra proved that
compound 423 interacts with G-A sheared base pair meanwhile disrupts the hydrogen
bonding between U-U. As expected, the base pairs flexibility, especially from the GA side,
contributes to the binding specificity. Ultimately, SAR analysis shows that any R-group
substitution will abolish its binding to GA:UU motif.
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4.2 Summary of RPIT implementation
In Chapter 3, we have implemented an interface threading scheme, called RPIT, for accurate
prediction of RNA-protein interaction partner using sequences as input. Interface threading
circumvents the pitfalls of pure sequence-based or structure-based methods, but identifies and
references a known RNA-protein interface as template to make inferences on the region
where the interaction occurs, and predict the interacting propensity based on the interface
profiles. Briefly, we generated the template database and five statistical scoring functions
from our unique collection of 5,471 non-redundant protein-RNA pairs (nrPR) from PDB
database. The statistical scoring functions evaluate the protein-binding propensity, RNAbinding propensity and RNA-protein binding complementarity as a function of residue type or
distance to interface. The interface threading algorithm takes into consideration the residue
types, secondary structure state, distance to interface residue, interaction types, and statistical
correction for nonspecific interaction while performing alignment. Upon evaluation, RPIT
random forest classifier (RPIT-RF) achieved the best performance in leave-protein-out crossvalidation (AUCRPIT-RF = 0.93, MCC = 0.69) and independent external validation using RPI
from yeast (AUCRPIT-RF = 0.71, MCC = 0.28). These predictions were significantly better than
that baseline model generated with Y-randomization or sequence identity attributes. The
attributes of the classifier (protein, RNA or interface profile), moreover, showed reasonable
contributions and removal any of them significantly impair the predictive ability. Compared
with RPISeq method, RPIT-RF achieved comparable accuracy in yeast validation set (~70%
accuracy) and superior accuracy in miRNA-protein interaction validation set (71% accuracy).
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4.3 Future directions in modeling RNA-small molecule interactions
Accurate scoring remains a great challenge in vHTS, even for protein target. When
optimizing RNA-ligand scoring function, we observed that distal mutation may significantly
affect the binding affinity in RNA system. For instance, the mutations on three distal base
pairs on SAM-I riboswitch (PDB ID: 3GX7) decrease the binding affinity by 300 fold but
cause minimal changes in the binding modes of SAM (RMSD < 0.5Å). Current scoring
functions are incapable of estimating free energy due to the thermodynamic changes of RNA
structure. Therefore, future works are still needed to derive RNA-specific atom typing [24],
intermolecular potential [104, 105] and nucleotide rotamer library for flexible docking.
Docking small molecule to flexible RNA, in particular, is considered more challenging due to
the lack of rotamer libraries. Current docking methods model the flexible RNA by soft
potentials [106], structural ensembles [6], or doing post-docking local optimization [27]. The
generation of RNA ensemble has led to a great success in developing specific inhibitor target
HIV-1 TAR RNA; however, the performance of RNA ensemble docking varies on targets,
scoring functions and other factors, and virtual screening performance may not be improved
when flexibility is introduced [107]. Thus, exploration of flexible RNA docking and scoring
will be one of the future directions of our research, which may be realized by incorporating
NMR RDC restraints into the scoring function.

In this thesis, three-step virtual screening pipeline has been successfully applied to a diseaserelated RNA motif, GA:UU tandem mismatch. To this end, we have identified a smallmolecule 423 that specifically recognizes GA:UU motif, validated by 1D and 2D NMR
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spectra. According to NMR structures we determined, the unbound-GA:UU motif flanked by
GC and AU base pairs shows sheared GA noncanonical base pair and UU is paired thru two
internucleotide H-bonds. In another NMR model (PDB ID: 2JSE [67]), however, the H-bonds
between UU are absent if GA:UU motif is flanked by two GC Watson-Crick base pairs. This
indicates that the GA:UU motif is intrinsically thermodynamically unstable, and can be easily
perturbed by surrounding nucleotides, as well as small molecules. Based on 1D and 2D NMR
spectra, compound 423 is able to perturb the UU base pair and but binds primarily to U7 and
G8 region. Surprisingly enough, the base pair stability of UU or next to UU side failed to
infer any variation of binding, but the base pair stability at GA side inversely correlates the
binding (tandem AU base pair > AU+GC > GC+AU). This specificity of RNA context fits the
3D model generated by MD simulation, in which the benzothiazole ring stacks on A21 and
the amine group form interaction with the AU base pair adjacent to G8:A21 base pair, not UU
base pair. However, this model failed to provide direct evidence to explain the destabilizing
of UU base pair. We speculated that the weaker peak from UU base pair is because of the
enhancement of the exchange rate of uridine imino hydrogen atom with the solvent since GA
base pair is propelled. As the mechanism of 423 being selective to GA:UA:AU context still
remains unclear, lead optimization and more SAR studies are currently undergoing and more
2D and 3D structural information are being collected to determine more molecular
mechanisms of its specificity. Meanwhile, we are designing more RNA vairants (e.g., GA:CC
motif) to further investigate binding motif more thoroughly. If necessary, compound 423 or
its derivatives can be designed as a molecular probe to quantify the GA:UU RNA expression
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in a cellular system, or to study the thermodynamic stability of a new RNA motif tagged with
GA:UU motif.

4.4 Future directions in modeling RNA-protein interactions
As a prototyping implementation, one of the central assumptions is that the interface and the
interaction type are generally inheritable from its homologous template. This has inevitably
simplified the interface threading problem because (i) RPI interface can be assembled by
discontinued fragments such that they might have different order in the target and the
template; (2) the confidence of interface threading can be greatly compromised if no
threading template could be identified; (3) homologous interfaces may not have the identical
interaction profile.

The limitation (1) could be partially mitigated by using the across-family templates, which
flattens the scoring function by only considering the convergently evolved interface motifs, as
did by iWARP [85]. As RPIT by nature is a template-based method, the limitation (2) is so far
infeasible to address without a consensus strategy, that is, to combine the template-free, de
novo scoring scheme or classifiers for consensus prediction. In fact, the conventional
definition of “template” (<30% sequence identity) need expansion under this circumstance.
RPIT has employed the best algorithms to date that greatly overcome the “twilight zone” of
sequence identities in template-based homology modeling (30%). Based on our evaluation,
the sequence identity demonstrated minimal contribution to RPI prediction compared with
random guessing (Fig. 3.13 and Fig. 3.14), which further indicates that sequence homology
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may be less informative than fold homology. In fact, if we could segment the entire RPI
interface into modular motifs or networks (as we proposed when discussing limitation (1)),
the common issue of “lack of homologous template” in template-based modeling may be
significantly mitigated. Finally, we may address the 3rd limitation by across-family interaction
network analysis, which aims to derive a feasible probabilistic model to make inferences on
preferable interaction types and interactive residues in that sub-chemical environment.

The second pitfall of RPIT is that, as we discussed in the Chapter 4.3, current implementation
is unable to account for the thermodynamic changes by distal mutations. Actually, the
underlying assumption of interface threading is that distal residue is generally less
informative than the residue that is closer to the interface when one predicts the binding.
Making such assumption simplifies the model, however, sacrificed the situation that the
mutations that destabilize the integrity of macromolecule (especially protein) may
significantly affect the binding affinity. More specifically, in the current RPIT implementation,
solvent accessible surface area (SASA) is not yet considered due to lack of biophysical model
to estimate the SASA of target interface, and when gap is presented. Based on the previous
study of RNA-protein interface, SASA is indeed a unique characteristic in RNA-protein
interface compared with that for protein-protein interface or protein-DNA interface [51].
More theoretical models which confers the template SASA to RNA-protein interface whose
SASA information is absent is aggressively needed for further optimization. Another aspect
of future work is to account for the thermodynamic contributions, which may involve the
incorporation of pre-calculated residue flexibility profile or NMR restraints.
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As a subsequent validation, we would like to examine the effectiveness of RPIT-RF for
discovery of novel miRNA-protein interaction. We are interested in discovering novel RPI
from human kinome and miRNAome. The hypothesis underlying this discovery-oriented
study is based on the finding of an RNA aptamer in complex with Bos taurus G proteincoupled receptor kinase 2 (GRK2) [108], and we speculated that the precursor miRNAs is
likely to function as endogenous inhibitor of protein kinase. To benchmark the speed of RPIT,
we have prioritized several promising miRNA-kinase interaction from randomly generated
825,600 pairs within 48 hours, and the follow-up experimental validation is ongoing. We are
hoping to identify paradigm-shift function of miRNA for better understanding of disease
related miRNA regulatory network in the near future.
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Appendix
Appendix 1-2 is based upon and reprinted with permission from Chen L, Calin GA, Zhang S.
Novel insights of structure-based modeling for RNA-targeted drug discovery. J Chem Inf
Model. Oct 22 2012;52(10):2741-2753. Copyright© 2012 American Chemical Society.

1. Docking parameters
GOLD 5.0.1 (CCDC): For docking and virtual screening, default parameters were set for
GOLD Fitness, ChemScore and ASP scores. "Allow early termination" and soft potentials
were turned off, and 200% search efficiency was employed to allow maximal exploration of
ligand conformation. We used 20 genetic algorithm (GA) runs with internal energy offset. For
pose reproduction analysis, the radius of the binding pocket was set as the maximal atomic
distance from the geometrical center of the ligand plus 3Å. The top 10 ranked docking poses
were retained for the 3D cumulative success rate analysis, cross-docking, and virtual
screening studies. To perform the native pose ranking and RMSD-score correlation study, we
found that the GOLD:GOLD Fitness combination with 100 population and 1000 maxops
could help us obtain high diversity and quality of the conformational decoys. Therefore,
GOLD:GOLD Fitness was employed to generate 100 conformational decoys for each target.
Rescoring was conducted with the GOLD rescore option, in which poses would be optimized
by the program.

Glide 5.6 (Schrödinger): Default parameters were employed for both Glide standard precision
(SP) and extra precision (XP) docking. Both GlideScore and Emodel score were evaluated.
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Multiple starting conformations were prepared with LigPrep2.0. The binding site was defined
as a box centered on the geometrical center of the bound ligand with each length equivalent to
the maximal atomic distance from the center of the ligand plus 3Å. Flexible hydroxyl groups
involved in the ligand binding were selected. The ligand internal energy offset option was
turned on. The top 10 ranked poses were minimized and retained. Rescoring was performed
by choosing "Refine (do not dock)" option. The decoys with no valid poses after
minimization were excluded in RMSD-score correlation analysis, but included in other
evaluations as bad poses (GlideScore or Emodel=10000).

Surflex 2.415 (Tripos): The binding pockets were defined by the area around the
experimentally determined ligand structure. The protomol_bloat=5 was set for pocket
identification. We used 4 additional starting poses and explored the best spin density
parameter using 3, 5 and 10. Self_scoring option was turned on. We kept 10 final poses for
analysis, and rescoring was performed by "-opt" flag.

rDock 2006.2: Radius of binding pocket was maximal atomic distance from the geometrical
center of the ligand plus 3Å, and site searching scoring function was RbtCavityGridSF.
Default parameters from “dock.prm” (standard scoring function) and “dock_solv.prm”
(scoring function with solvation term) were used for scoring. We performed 200 separate runs
for each docking exercise in order to cover enough conformational space. Top 10 ranked
poses were retained. Rescoring was performed using the parameter in “minimise.prm” and
“minimize_solv.prm” for rescoring with and without the solvation term, respectively.
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AutoDock 4.1: The definition of grid box was the same as that of Glide with 0.2Å grid
spacing. Lamarckian Genetic Algorithm (LGA) was used to perform 100 GA runs. Other
parameters, such as 200 individuals in populations, 500,000 maximum energy evaluations,
and 30,000 maximum generations were employed for LGA. The top 10 clusters were retained
for analysis. Rescoring was performed using AutoDockTools4 using optimized parameters.

2. Volume under the surface (VUS) calculation
VUS were estimated as the sum of the volume of all triangular prism units under the surface,
therefore

VUS = ∑ (Vtriangular _ prism )
The volume of each triangular prism unit (Vtriangular prism) was calculated by the following
equation. Each triangular prism unit was broken down into a tetrahedron (V1) and a tetragonal
pyramid (V2), as illustrated below. Z1, Z2 and Z3 were the Z coordinates of triangle vertices on
the 3D cumulative success rate surface, and we assume Z1 ≤ Z2 ≤ Z3. Thus,

Vtriangular _ prism= V1 + V2
1
1 Z + Z3
= ( ×1× 0.5 × Z1 ) + ( × 2
×1× 0.5)
6
3
2
1
( Z1 + Z 2 + Z 3 )
=
12
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